US20200093713A1 - Method for improving the sensorial properties of oil-in-water emulsions - Google Patents
Method for improving the sensorial properties of oil-in-water emulsions Download PDFInfo
- Publication number
- US20200093713A1 US20200093713A1 US16/470,395 US201716470395A US2020093713A1 US 20200093713 A1 US20200093713 A1 US 20200093713A1 US 201716470395 A US201716470395 A US 201716470395A US 2020093713 A1 US2020093713 A1 US 2020093713A1
- Authority
- US
- United States
- Prior art keywords
- weight
- equal
- oil
- less
- emulsion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000839 emulsion Substances 0.000 title claims abstract description 126
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 70
- 238000000034 method Methods 0.000 title claims abstract description 47
- 239000000203 mixture Substances 0.000 claims abstract description 76
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 67
- 230000000699 topical effect Effects 0.000 claims abstract description 26
- 125000004122 cyclic group Chemical group 0.000 claims abstract description 24
- 125000002015 acyclic group Chemical group 0.000 claims abstract description 23
- 229930195733 hydrocarbon Natural products 0.000 claims abstract description 22
- 150000002430 hydrocarbons Chemical class 0.000 claims abstract description 22
- 230000007480 spreading Effects 0.000 claims description 39
- 238000003892 spreading Methods 0.000 claims description 39
- 150000001335 aliphatic alkanes Chemical class 0.000 claims description 32
- 239000012071 phase Substances 0.000 claims description 22
- 239000007764 o/w emulsion Substances 0.000 claims description 21
- 239000003795 chemical substances by application Substances 0.000 claims description 20
- 150000001924 cycloalkanes Chemical class 0.000 claims description 20
- 230000001953 sensory effect Effects 0.000 claims description 19
- 230000005855 radiation Effects 0.000 claims description 17
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 14
- 239000008346 aqueous phase Substances 0.000 claims description 11
- 230000000694 effects Effects 0.000 claims description 10
- 230000004224 protection Effects 0.000 claims description 10
- 239000004094 surface-active agent Substances 0.000 claims description 10
- 206010015150 Erythema Diseases 0.000 claims description 9
- 229930195734 saturated hydrocarbon Natural products 0.000 claims description 7
- 239000004408 titanium dioxide Substances 0.000 claims description 7
- 238000011282 treatment Methods 0.000 claims description 4
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 claims description 3
- OLZQCKXRHXVSRM-UHFFFAOYSA-N 2-(3-ethyl-1-phenylheptylidene)-1,3-dimethoxyimidazolidine-4,5-dione propanoic acid Chemical compound C(CC)(=O)O.C(C)C(CC(C1=CC=CC=C1)=C1N(C(C(N1OC)=O)=O)OC)CCCC OLZQCKXRHXVSRM-UHFFFAOYSA-N 0.000 claims description 3
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 claims description 3
- FDATWRLUYRHCJE-UHFFFAOYSA-N diethylamino hydroxybenzoyl hexyl benzoate Chemical compound CCCCCCOC(=O)C1=CC=CC=C1C(=O)C1=CC=C(N(CC)CC)C=C1O FDATWRLUYRHCJE-UHFFFAOYSA-N 0.000 claims description 3
- 231100000321 erythema Toxicity 0.000 claims description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 3
- 208000000453 Skin Neoplasms Diseases 0.000 claims description 2
- 206010042496 Sunburn Diseases 0.000 claims description 2
- 208000017520 skin disease Diseases 0.000 claims description 2
- 230000001225 therapeutic effect Effects 0.000 claims description 2
- 239000000516 sunscreening agent Substances 0.000 abstract description 7
- 210000003491 skin Anatomy 0.000 description 62
- 239000003921 oil Substances 0.000 description 43
- 235000019198 oils Nutrition 0.000 description 35
- 239000000047 product Substances 0.000 description 31
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 25
- 239000001993 wax Substances 0.000 description 24
- -1 fatty acid esters Chemical class 0.000 description 23
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 21
- 229920001577 copolymer Polymers 0.000 description 18
- 239000002537 cosmetic Substances 0.000 description 17
- 229920001296 polysiloxane Polymers 0.000 description 16
- 239000000126 substance Substances 0.000 description 16
- 230000035807 sensation Effects 0.000 description 15
- 235000019615 sensations Nutrition 0.000 description 15
- 239000000284 extract Substances 0.000 description 14
- 238000009472 formulation Methods 0.000 description 14
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 13
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 12
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 12
- 238000011156 evaluation Methods 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 11
- 235000014113 dietary fatty acids Nutrition 0.000 description 11
- 239000000194 fatty acid Substances 0.000 description 11
- 229930195729 fatty acid Natural products 0.000 description 11
- 239000013543 active substance Substances 0.000 description 10
- 150000001875 compounds Chemical class 0.000 description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 235000011187 glycerol Nutrition 0.000 description 9
- 239000004615 ingredient Substances 0.000 description 9
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 9
- 235000013980 iron oxide Nutrition 0.000 description 9
- VBMVTYDPPZVILR-UHFFFAOYSA-N iron(2+);oxygen(2-) Chemical class [O-2].[Fe+2] VBMVTYDPPZVILR-UHFFFAOYSA-N 0.000 description 9
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Chemical compound CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 9
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 8
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 8
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 8
- 150000004665 fatty acids Chemical class 0.000 description 8
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 8
- 229940114081 cinnamate Drugs 0.000 description 7
- 150000002148 esters Chemical class 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 239000000419 plant extract Substances 0.000 description 7
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 6
- CAHKINHBCWCHCF-UHFFFAOYSA-N N-acetyltyrosine Chemical compound CC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 CAHKINHBCWCHCF-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 230000009471 action Effects 0.000 description 6
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 6
- 239000003995 emulsifying agent Substances 0.000 description 6
- 150000002191 fatty alcohols Chemical class 0.000 description 6
- 230000006872 improvement Effects 0.000 description 6
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 6
- 230000000475 sunscreen effect Effects 0.000 description 6
- 229920001897 terpolymer Polymers 0.000 description 6
- 235000015112 vegetable and seed oil Nutrition 0.000 description 6
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 5
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 5
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 5
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 5
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 description 5
- 239000005642 Oleic acid Substances 0.000 description 5
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 5
- 235000021355 Stearic acid Nutrition 0.000 description 5
- 239000003205 fragrance Substances 0.000 description 5
- 229920001519 homopolymer Polymers 0.000 description 5
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 5
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 5
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 5
- 239000000049 pigment Substances 0.000 description 5
- 229920000058 polyacrylate Polymers 0.000 description 5
- 239000008117 stearic acid Substances 0.000 description 5
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 4
- FNWWOHKUXFTKGN-UHFFFAOYSA-N 2-methyl-Hexadecane Chemical compound CCCCCCCCCCCCCCC(C)C FNWWOHKUXFTKGN-UHFFFAOYSA-N 0.000 description 4
- RJWUMFHQJJBBOD-UHFFFAOYSA-N 2-methylheptadecane Chemical compound CCCCCCCCCCCCCCCC(C)C RJWUMFHQJJBBOD-UHFFFAOYSA-N 0.000 description 4
- KVQVGSDBGJXNGV-UHFFFAOYSA-N 2-methyloctadecane Chemical compound CCCCCCCCCCCCCCCCC(C)C KVQVGSDBGJXNGV-UHFFFAOYSA-N 0.000 description 4
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 4
- UBBJYPLLGREQRW-UHFFFAOYSA-N 4-hydroxy-2,3-bis(hydroxymethyl)-n-methylbut-2-enamide Chemical compound CNC(=O)C(CO)=C(CO)CO UBBJYPLLGREQRW-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- 239000005639 Lauric acid Substances 0.000 description 4
- 235000021314 Palmitic acid Nutrition 0.000 description 4
- 241001135917 Vitellaria paradoxa Species 0.000 description 4
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 4
- 229960000846 camphor Drugs 0.000 description 4
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 4
- 238000007046 ethoxylation reaction Methods 0.000 description 4
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 4
- 210000004400 mucous membrane Anatomy 0.000 description 4
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 230000002035 prolonged effect Effects 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 4
- 239000002562 thickening agent Substances 0.000 description 4
- 229930003799 tocopherol Natural products 0.000 description 4
- 229960001295 tocopherol Drugs 0.000 description 4
- 235000010384 tocopherol Nutrition 0.000 description 4
- 239000011732 tocopherol Substances 0.000 description 4
- WBYWAXJHAXSJNI-VOTSOKGWSA-M trans-cinnamate Chemical compound [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 4
- 230000000007 visual effect Effects 0.000 description 4
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 4
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- 102100030089 ATP-dependent RNA helicase DHX8 Human genes 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 101000864666 Homo sapiens ATP-dependent RNA helicase DHX8 Proteins 0.000 description 3
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 3
- FGUZFFWTBWJBIL-XWVZOOPGSA-N [(1r)-1-[(2s,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)O[C@H](CO)[C@H]1OC[C@H](O)[C@H]1O FGUZFFWTBWJBIL-XWVZOOPGSA-N 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 229920000615 alginic acid Polymers 0.000 description 3
- 235000010443 alginic acid Nutrition 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 3
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 229940120503 dihydroxyacetone Drugs 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- 239000003974 emollient agent Substances 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 125000004494 ethyl ester group Chemical group 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- CDAISMWEOUEBRE-UHFFFAOYSA-N inositol Chemical compound OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 3
- SNVLJLYUUXKWOJ-UHFFFAOYSA-N methylidenecarbene Chemical compound C=[C] SNVLJLYUUXKWOJ-UHFFFAOYSA-N 0.000 description 3
- 239000010445 mica Substances 0.000 description 3
- 229910052618 mica group Inorganic materials 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 229940088644 n,n-dimethylacrylamide Drugs 0.000 description 3
- YLGYACDQVQQZSW-UHFFFAOYSA-N n,n-dimethylprop-2-enamide Chemical compound CN(C)C(=O)C=C YLGYACDQVQQZSW-UHFFFAOYSA-N 0.000 description 3
- RZJRJXONCZWCBN-UHFFFAOYSA-N octadecane Chemical compound CCCCCCCCCCCCCCCCCC RZJRJXONCZWCBN-UHFFFAOYSA-N 0.000 description 3
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical compound C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 3
- 239000010773 plant oil Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 229940057910 shea butter Drugs 0.000 description 3
- 229920002545 silicone oil Polymers 0.000 description 3
- 229920002379 silicone rubber Polymers 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 229940057429 sorbitan isostearate Drugs 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 150000005846 sugar alcohols Polymers 0.000 description 3
- 230000008719 thickening Effects 0.000 description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
- 239000000811 xylitol Substances 0.000 description 3
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 3
- 229960002675 xylitol Drugs 0.000 description 3
- 235000010447 xylitol Nutrition 0.000 description 3
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- DGSZGZSCHSQXFV-UHFFFAOYSA-N 2,3-bis(2-ethylhexanoyloxy)propyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(OC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DGSZGZSCHSQXFV-UHFFFAOYSA-N 0.000 description 2
- WEBYTKYOQHOCCX-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol 1-phenoxyethanol Chemical compound C(C)C(O)(C(O)CO)CCCCCC.O(C1=CC=CC=C1)C(C)O WEBYTKYOQHOCCX-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- SBVKVAIECGDBTC-UHFFFAOYSA-N 4-hydroxy-2-methylidenebutanamide Chemical compound NC(=O)C(=C)CCO SBVKVAIECGDBTC-UHFFFAOYSA-N 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
- 235000021357 Behenic acid Nutrition 0.000 description 2
- ZCTQGTTXIYCGGC-UHFFFAOYSA-N Benzyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 ZCTQGTTXIYCGGC-UHFFFAOYSA-N 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241000723346 Cinnamomum camphora Species 0.000 description 2
- 235000007716 Citrus aurantium Nutrition 0.000 description 2
- 240000003791 Citrus myrtifolia Species 0.000 description 2
- 235000000228 Citrus myrtifolia Nutrition 0.000 description 2
- 235000016646 Citrus taiwanica Nutrition 0.000 description 2
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical compound [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- 229920000926 Galactomannan Polymers 0.000 description 2
- 235000003222 Helianthus annuus Nutrition 0.000 description 2
- 244000020551 Helianthus annuus Species 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 244000302544 Luffa aegyptiaca Species 0.000 description 2
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 2
- 229920005372 Plexiglas® Polymers 0.000 description 2
- 235000009984 Pterocarpus indicus Nutrition 0.000 description 2
- 244000086363 Pterocarpus indicus Species 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 2
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 235000019486 Sunflower oil Nutrition 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- 230000006750 UV protection Effects 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 235000001667 Vitex agnus castus Nutrition 0.000 description 2
- 244000063464 Vitex agnus-castus Species 0.000 description 2
- LWZFANDGMFTDAV-BURFUSLBSA-N [(2r)-2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O LWZFANDGMFTDAV-BURFUSLBSA-N 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- 125000005250 alkyl acrylate group Chemical group 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- HIMXGTXNXJYFGB-UHFFFAOYSA-N alloxan Chemical compound O=C1NC(=O)C(=O)C(=O)N1 HIMXGTXNXJYFGB-UHFFFAOYSA-N 0.000 description 2
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 2
- 229940063655 aluminum stearate Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 229940116226 behenic acid Drugs 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- FQUNFJULCYSSOP-UHFFFAOYSA-N bisoctrizole Chemical compound N1=C2C=CC=CC2=NN1C1=CC(C(C)(C)CC(C)(C)C)=CC(CC=2C(=C(C=C(C=2)C(C)(C)CC(C)(C)C)N2N=C3C=CC=CC3=N2)O)=C1O FQUNFJULCYSSOP-UHFFFAOYSA-N 0.000 description 2
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 229930008380 camphor Natural products 0.000 description 2
- 235000021466 carotenoid Nutrition 0.000 description 2
- 150000001747 carotenoids Chemical class 0.000 description 2
- 230000023402 cell communication Effects 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229940081733 cetearyl alcohol Drugs 0.000 description 2
- 235000009347 chasteberry Nutrition 0.000 description 2
- 229940108925 copper gluconate Drugs 0.000 description 2
- 229920006037 cross link polymer Polymers 0.000 description 2
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 2
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- DLAHAXOYRFRPFQ-UHFFFAOYSA-N dodecyl benzoate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC=CC=C1 DLAHAXOYRFRPFQ-UHFFFAOYSA-N 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 2
- DCAYPVUWAIABOU-UHFFFAOYSA-N hexadecane Chemical compound CCCCCCCCCCCCCCCC DCAYPVUWAIABOU-UHFFFAOYSA-N 0.000 description 2
- 229940051250 hexylene glycol Drugs 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- 238000010907 mechanical stirring Methods 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- LQERIDTXQFOHKA-UHFFFAOYSA-N nonadecane Chemical compound CCCCCCCCCCCCCCCCCCC LQERIDTXQFOHKA-UHFFFAOYSA-N 0.000 description 2
- QUAMTGJKVDWJEQ-UHFFFAOYSA-N octabenzone Chemical compound OC1=CC(OCCCCCCCC)=CC=C1C(=O)C1=CC=CC=C1 QUAMTGJKVDWJEQ-UHFFFAOYSA-N 0.000 description 2
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 2
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 2
- 229960001679 octinoxate Drugs 0.000 description 2
- 229960000601 octocrylene Drugs 0.000 description 2
- SSZBUIDZHHWXNJ-UHFFFAOYSA-N palmityl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC SSZBUIDZHHWXNJ-UHFFFAOYSA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- YCOZIPAWZNQLMR-UHFFFAOYSA-N pentadecane Chemical compound CCCCCCCCCCCCCCC YCOZIPAWZNQLMR-UHFFFAOYSA-N 0.000 description 2
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 2
- ZQBAKBUEJOMQEX-UHFFFAOYSA-N phenyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OC1=CC=CC=C1 ZQBAKBUEJOMQEX-UHFFFAOYSA-N 0.000 description 2
- 229920000867 polyelectrolyte Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 229940068965 polysorbates Drugs 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 229950006451 sorbitan laurate Drugs 0.000 description 2
- 235000011067 sorbitan monolaureate Nutrition 0.000 description 2
- 229950004959 sorbitan oleate Drugs 0.000 description 2
- 229950003429 sorbitan palmitate Drugs 0.000 description 2
- 229950011392 sorbitan stearate Drugs 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 229960002920 sorbitol Drugs 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 239000002600 sunflower oil Substances 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 238000001429 visible spectrum Methods 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000012855 volatile organic compound Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- KZVAAIRBJJYZOW-VPENINKCSA-N (2r,3r,4s)-2-(hydroxymethyl)oxolane-3,4-diol Chemical compound OC[C@H]1OC[C@H](O)[C@H]1O KZVAAIRBJJYZOW-VPENINKCSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- DJPVXOYGQKTRPA-KRWDZBQOSA-N (2s)-2-(decanoylamino)-3-(4-hydroxyphenyl)propanoic acid Chemical compound CCCCCCCCCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 DJPVXOYGQKTRPA-KRWDZBQOSA-N 0.000 description 1
- DKBVMOJIVATKCZ-NSHDSACASA-N (2s)-2-acetamido-3-[4-[dihydroxy(methyl)silyl]oxyphenyl]propanoic acid Chemical compound CC(=O)N[C@H](C(O)=O)CC1=CC=C(O[Si](C)(O)O)C=C1 DKBVMOJIVATKCZ-NSHDSACASA-N 0.000 description 1
- GYDYJUYZBRGMCC-INIZCTEOSA-N (2s)-2-amino-6-(dodecanoylamino)hexanoic acid Chemical compound CCCCCCCCCCCC(=O)NCCCC[C@H](N)C(O)=O GYDYJUYZBRGMCC-INIZCTEOSA-N 0.000 description 1
- LTBAFRQKFIMYQK-DLWPFLMGSA-N (2s,3r,4r)-5-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentane-1,2,3,4-tetrol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O LTBAFRQKFIMYQK-DLWPFLMGSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- 229940031723 1,2-octanediol Drugs 0.000 description 1
- QLAJNZSPVITUCQ-UHFFFAOYSA-N 1,3,2-dioxathietane 2,2-dioxide Chemical compound O=S1(=O)OCO1 QLAJNZSPVITUCQ-UHFFFAOYSA-N 0.000 description 1
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- OVYMWJFNQQOJBU-UHFFFAOYSA-N 1-octanoyloxypropan-2-yl octanoate Chemical compound CCCCCCCC(=O)OCC(C)OC(=O)CCCCCCC OVYMWJFNQQOJBU-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- MEZZCSHVIGVWFI-UHFFFAOYSA-N 2,2'-Dihydroxy-4-methoxybenzophenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1O MEZZCSHVIGVWFI-UHFFFAOYSA-N 0.000 description 1
- OAYXUHPQHDHDDZ-UHFFFAOYSA-N 2-(2-butoxyethoxy)ethanol Chemical compound CCCCOCCOCCO OAYXUHPQHDHDDZ-UHFFFAOYSA-N 0.000 description 1
- OUCGLXKNITVPJS-OUKQBFOZSA-N 2-ethylhexyl (e)-3-phenylprop-2-enoate Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=CC=C1 OUCGLXKNITVPJS-OUKQBFOZSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- QENRKQYUEGJNNZ-UHFFFAOYSA-N 2-methyl-1-(prop-2-enoylamino)propane-1-sulfonic acid Chemical compound CC(C)C(S(O)(=O)=O)NC(=O)C=C QENRKQYUEGJNNZ-UHFFFAOYSA-N 0.000 description 1
- QWGRWMMWNDWRQN-UHFFFAOYSA-N 2-methylpropane-1,3-diol Chemical compound OCC(C)CO QWGRWMMWNDWRQN-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- WMJBVALTYVXGHW-UHFFFAOYSA-N 3,3-diphenylprop-2-enoic acid Chemical class C=1C=CC=CC=1C(=CC(=O)O)C1=CC=CC=C1 WMJBVALTYVXGHW-UHFFFAOYSA-N 0.000 description 1
- APINLBHZXUNBHE-UHFFFAOYSA-N 3,4-diethyl-2-hexylphenol;5-methoxy-4-phenyltriazine Chemical compound COC1=CN=NN=C1C1=CC=CC=C1.CCCCCCC1=C(O)C=CC(CC)=C1CC APINLBHZXUNBHE-UHFFFAOYSA-N 0.000 description 1
- AGNTUZCMJBTHOG-UHFFFAOYSA-N 3-[3-(2,3-dihydroxypropoxy)-2-hydroxypropoxy]propane-1,2-diol Chemical compound OCC(O)COCC(O)COCC(O)CO AGNTUZCMJBTHOG-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 description 1
- OGPRHLDYFOTGOM-UHFFFAOYSA-N 4-(3-ethyl-2-hexoxy-4-methoxyphenyl)-5-phenyl-1H-triazin-6-one Chemical compound C(C)C=1C(=C(C=CC=1OC)C1=NN=NC(=C1C1=CC=CC=C1)O)OCCCCCC OGPRHLDYFOTGOM-UHFFFAOYSA-N 0.000 description 1
- DBLDQZASZZMNSL-QMMMGPOBSA-N 4-[(2s)-2-amino-3-hydroxypropyl]phenol Chemical compound OC[C@@H](N)CC1=CC=C(O)C=C1 DBLDQZASZZMNSL-QMMMGPOBSA-N 0.000 description 1
- VMRIVYANZGSGRV-UHFFFAOYSA-N 4-phenyl-2h-triazin-5-one Chemical compound OC1=CN=NN=C1C1=CC=CC=C1 VMRIVYANZGSGRV-UHFFFAOYSA-N 0.000 description 1
- JOKBLKCZHGIRNO-UHFFFAOYSA-N 5-benzoyl-2-hydroxybenzoic acid Chemical compound C1=C(O)C(C(=O)O)=CC(C(=O)C=2C=CC=CC=2)=C1 JOKBLKCZHGIRNO-UHFFFAOYSA-N 0.000 description 1
- RDBLNMQDEWOUIB-UHFFFAOYSA-N 5-methyl-2-phenyl-1,3-benzoxazole Chemical compound N=1C2=CC(C)=CC=C2OC=1C1=CC=CC=C1 RDBLNMQDEWOUIB-UHFFFAOYSA-N 0.000 description 1
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 1
- 235000006491 Acacia senegal Nutrition 0.000 description 1
- 240000005020 Acaciella glauca Species 0.000 description 1
- 235000009434 Actinidia chinensis Nutrition 0.000 description 1
- 244000298697 Actinidia deliciosa Species 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 1
- 241000157282 Aesculus Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 235000006667 Aleurites moluccana Nutrition 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 241000242757 Anthozoa Species 0.000 description 1
- 235000000832 Ayote Nutrition 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 241000212973 Baphia Species 0.000 description 1
- 241000349750 Baphia nitida Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- HRQKOYFGHJYEFS-UHFFFAOYSA-N Beta psi-carotene Chemical compound CC(C)=CCCC(C)=CC=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C HRQKOYFGHJYEFS-UHFFFAOYSA-N 0.000 description 1
- 208000035985 Body Odor Diseases 0.000 description 1
- DHFUFHYLYSCIJY-WSGIOKLISA-N CCCCCCCCCCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O Chemical compound CCCCCCCCCCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DHFUFHYLYSCIJY-WSGIOKLISA-N 0.000 description 1
- 235000003880 Calendula Nutrition 0.000 description 1
- 240000001432 Calendula officinalis Species 0.000 description 1
- 240000005589 Calophyllum inophyllum Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 235000009467 Carica papaya Nutrition 0.000 description 1
- 240000006432 Carica papaya Species 0.000 description 1
- 235000014653 Carica parviflora Nutrition 0.000 description 1
- 239000001884 Cassia gum Substances 0.000 description 1
- 229920003043 Cellulose fiber Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 240000004244 Cucurbita moschata Species 0.000 description 1
- 235000009854 Cucurbita moschata Nutrition 0.000 description 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- AEMOLEFTQBMNLQ-BZINKQHNSA-N D-Guluronic Acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@@H](O)[C@H]1O AEMOLEFTQBMNLQ-BZINKQHNSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- MNQZXJOMYWMBOU-VKHMYHEASA-N D-glyceraldehyde Chemical compound OC[C@@H](O)C=O MNQZXJOMYWMBOU-VKHMYHEASA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-VANFPWTGSA-N D-mannopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H]1O AEMOLEFTQBMNLQ-VANFPWTGSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- JDRSMPFHFNXQRB-CMTNHCDUSA-N Decyl beta-D-threo-hexopyranoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)C(O)[C@H](O)C1O JDRSMPFHFNXQRB-CMTNHCDUSA-N 0.000 description 1
- 239000004287 Dehydroacetic acid Substances 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 235000016622 Filipendula ulmaria Nutrition 0.000 description 1
- 244000061544 Filipendula vulgaris Species 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 241000195480 Fucus Species 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 235000019487 Hazelnut oil Nutrition 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- SHBUUTHKGIVMJT-UHFFFAOYSA-N Hydroxystearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OO SHBUUTHKGIVMJT-UHFFFAOYSA-N 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- 241001598113 Laminaria digitata Species 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- OXPCWUWUWIWSGI-MSUUIHNZSA-N Lauryl oleate Chemical compound CCCCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC OXPCWUWUWIWSGI-MSUUIHNZSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 241000208467 Macadamia Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 235000017011 Mandorlo dulce Nutrition 0.000 description 1
- 244000076313 Mandorlo dulce Species 0.000 description 1
- 102400000740 Melanocyte-stimulating hormone alpha Human genes 0.000 description 1
- 101710200814 Melanotropin alpha Proteins 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 235000006161 Mucuna pruriens Nutrition 0.000 description 1
- 244000111261 Mucuna pruriens Species 0.000 description 1
- UOIBFJBJAWHQNM-JRUKXMRZSA-N N-Oleoyl tyrosine Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 UOIBFJBJAWHQNM-JRUKXMRZSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 241000234479 Narcissus Species 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000008753 Papaver somniferum Nutrition 0.000 description 1
- 240000001090 Papaver somniferum Species 0.000 description 1
- 235000011925 Passiflora alata Nutrition 0.000 description 1
- 235000000370 Passiflora edulis Nutrition 0.000 description 1
- 235000011922 Passiflora incarnata Nutrition 0.000 description 1
- 240000002690 Passiflora mixta Species 0.000 description 1
- 235000013750 Passiflora mixta Nutrition 0.000 description 1
- 235000013731 Passiflora van volxemii Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000019497 Pistachio oil Nutrition 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 241000750717 Pterocarpus erinaceus Species 0.000 description 1
- 241000750726 Pterocarpus osun Species 0.000 description 1
- 241000752191 Pterocarpus soyauxii Species 0.000 description 1
- 244000294611 Punica granatum Species 0.000 description 1
- 235000014360 Punica granatum Nutrition 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 240000001890 Ribes hudsonianum Species 0.000 description 1
- 235000016954 Ribes hudsonianum Nutrition 0.000 description 1
- 235000001466 Ribes nigrum Nutrition 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 241000605385 Ruscus Species 0.000 description 1
- 235000003500 Ruscus aculeatus Nutrition 0.000 description 1
- 240000000353 Ruscus aculeatus Species 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 241000124033 Salix Species 0.000 description 1
- 208000036367 Sensation of heaviness Diseases 0.000 description 1
- 244000044822 Simmondsia californica Species 0.000 description 1
- 235000004433 Simmondsia californica Nutrition 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 235000001484 Trigonella foenum graecum Nutrition 0.000 description 1
- 244000250129 Trigonella foenum graecum Species 0.000 description 1
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 240000000851 Vaccinium corymbosum Species 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- GZCGUPFRVQAUEE-KCDKBNATSA-N aldehydo-D-galactose Chemical group OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-KCDKBNATSA-N 0.000 description 1
- 229940108929 alfalfa oil Drugs 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- 229940062909 amyl salicylate Drugs 0.000 description 1
- 229940083987 anhydroxylitol Drugs 0.000 description 1
- 229920006318 anionic polymer Polymers 0.000 description 1
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical class NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000003356 anti-rheumatic effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 239000010478 argan oil Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229940067599 ascorbyl glucoside Drugs 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960001716 benzalkonium Drugs 0.000 description 1
- CYDRXTMLKJDRQH-UHFFFAOYSA-N benzododecinium Chemical compound CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 CYDRXTMLKJDRQH-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- BJFLSHMHTPAZHO-UHFFFAOYSA-N benzotriazole Chemical compound [CH]1C=CC=C2N=NN=C21 BJFLSHMHTPAZHO-UHFFFAOYSA-N 0.000 description 1
- 239000012964 benzotriazole Substances 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- AEMOLEFTQBMNLQ-UHFFFAOYSA-N beta-D-galactopyranuronic acid Natural products OC1OC(C(O)=O)C(O)C(O)C1O AEMOLEFTQBMNLQ-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- WXNRYSGJLQFHBR-UHFFFAOYSA-N bis(2,4-dihydroxyphenyl)methanone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=C(O)C=C1O WXNRYSGJLQFHBR-UHFFFAOYSA-N 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 229940094199 black currant oil Drugs 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 235000021324 borage oil Nutrition 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- DHAZIUXMHRHVMP-UHFFFAOYSA-N butyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCC DHAZIUXMHRHVMP-UHFFFAOYSA-N 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 244000192479 candlenut Species 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 235000013709 carrot oil Nutrition 0.000 description 1
- 235000019318 cassia gum Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 229910000420 cerium oxide Inorganic materials 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- UOUJSJZBMCDAEU-UHFFFAOYSA-N chromium(3+);oxygen(2-) Chemical class [O-2].[O-2].[O-2].[Cr+3].[Cr+3] UOUJSJZBMCDAEU-UHFFFAOYSA-N 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 229940080421 coco glucoside Drugs 0.000 description 1
- 235000020197 coconut milk Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000010635 coffee oil Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000008271 cosmetic emulsion Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 230000002249 decongestive effect Effects 0.000 description 1
- JDRSMPFHFNXQRB-IBEHDNSVSA-N decyl glucoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O JDRSMPFHFNXQRB-IBEHDNSVSA-N 0.000 description 1
- 229940073499 decyl glucoside Drugs 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 229940061632 dehydroacetic acid Drugs 0.000 description 1
- 235000019258 dehydroacetic acid Nutrition 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 1
- 229960001259 diclofenac Drugs 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- UQPHVQVXLPRNCX-UHFFFAOYSA-N erythrulose Chemical compound OCC(O)C(=O)CO UQPHVQVXLPRNCX-UHFFFAOYSA-N 0.000 description 1
- KCDAMWRCUXGACP-DHZHZOJOSA-N ethyl (e)-2-cyano-3-phenylprop-2-enoate Chemical compound CCOC(=O)C(\C#N)=C\C1=CC=CC=C1 KCDAMWRCUXGACP-DHZHZOJOSA-N 0.000 description 1
- HPMLGOFBKNGJAM-ONEGZZNKSA-N ethyl (e)-3-(1h-imidazol-5-yl)prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CN=CN1 HPMLGOFBKNGJAM-ONEGZZNKSA-N 0.000 description 1
- NYNCZOLNVTXTTP-UHFFFAOYSA-N ethyl 2-(1,3-dioxoisoindol-2-yl)acetate Chemical compound C1=CC=C2C(=O)N(CC(=O)OCC)C(=O)C2=C1 NYNCZOLNVTXTTP-UHFFFAOYSA-N 0.000 description 1
- IAJNXBNRYMEYAZ-UHFFFAOYSA-N ethyl 2-cyano-3,3-diphenylprop-2-enoate Chemical compound C=1C=CC=CC=1C(=C(C#N)C(=O)OCC)C1=CC=CC=C1 IAJNXBNRYMEYAZ-UHFFFAOYSA-N 0.000 description 1
- TUKWPCXMNZAXLO-UHFFFAOYSA-N ethyl 2-nonylsulfanyl-4-oxo-1h-pyrimidine-6-carboxylate Chemical compound CCCCCCCCCSC1=NC(=O)C=C(C(=O)OCC)N1 TUKWPCXMNZAXLO-UHFFFAOYSA-N 0.000 description 1
- XCRHYAQWBYDRGV-UHFFFAOYSA-N ethyl 3-(4-propan-2-ylphenyl)prop-2-enoate Chemical compound CCOC(=O)C=CC1=CC=C(C(C)C)C=C1 XCRHYAQWBYDRGV-UHFFFAOYSA-N 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 229940068171 ethyl hexyl salicylate Drugs 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 229940093470 ethylene Drugs 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 150000002194 fatty esters Chemical class 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 239000011663 gamma-carotene Substances 0.000 description 1
- HRQKOYFGHJYEFS-RZWPOVEWSA-N gamma-carotene Natural products C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/C=1C(C)(C)CCCC=1C)\C)/C)\C)(\C=C\C=C(/CC/C=C(\C)/C)\C)/C HRQKOYFGHJYEFS-RZWPOVEWSA-N 0.000 description 1
- 235000000633 gamma-carotene Nutrition 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 239000010468 hazelnut oil Substances 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- 229920000140 heteropolymer Polymers 0.000 description 1
- QAKXLTNAJLFSQC-UHFFFAOYSA-N hexadecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC QAKXLTNAJLFSQC-UHFFFAOYSA-N 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 235000010181 horse chestnut Nutrition 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 description 1
- 230000003165 hydrotropic effect Effects 0.000 description 1
- AIPVRBGBHQDAPX-UHFFFAOYSA-N hydroxy(methyl)silane Chemical compound C[SiH2]O AIPVRBGBHQDAPX-UHFFFAOYSA-N 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 229940072106 hydroxystearate Drugs 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- ZRQCSGOWNKXTHJ-UHFFFAOYSA-N imidazolidine-4,5-dione propanoic acid Chemical compound C(CC)(=O)O.O=C1C(NCN1)=O ZRQCSGOWNKXTHJ-UHFFFAOYSA-N 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 239000000077 insect repellent Substances 0.000 description 1
- 102000006495 integrins Human genes 0.000 description 1
- 108010044426 integrins Proteins 0.000 description 1
- 229940078545 isocetyl stearate Drugs 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940089456 isopropyl stearate Drugs 0.000 description 1
- 239000012182 japan wax Substances 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000003077 lignite Substances 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 150000002632 lipids Chemical group 0.000 description 1
- 230000002366 lipolytic effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 229940063002 magnesium palmitate Drugs 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- ABSWXCXMXIZDSN-UHFFFAOYSA-L magnesium;hexadecanoate Chemical compound [Mg+2].CCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCC([O-])=O ABSWXCXMXIZDSN-UHFFFAOYSA-L 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 229910001437 manganese ion Inorganic materials 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000010507 melon oil Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical compound [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 description 1
- PABHEXWDYRTPBQ-UHFFFAOYSA-N methyl 3-[2,5-di(propan-2-yl)phenyl]prop-2-enoate Chemical compound COC(=O)C=CC1=CC(C(C)C)=CC=C1C(C)C PABHEXWDYRTPBQ-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- MJVGBKJNTFCUJM-UHFFFAOYSA-N mexenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(C)C=C1 MJVGBKJNTFCUJM-UHFFFAOYSA-N 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000012764 mineral filler Substances 0.000 description 1
- 239000006083 mineral thickener Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 150000002771 monosaccharide derivatives Chemical class 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229940038384 octadecane Drugs 0.000 description 1
- 125000004365 octenyl group Chemical group C(=CCCCCCC)* 0.000 description 1
- IIGMITQLXAGZTL-UHFFFAOYSA-N octyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCC IIGMITQLXAGZTL-UHFFFAOYSA-N 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- 229940104349 oleoyl tyrosine Drugs 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 239000003605 opacifier Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- SOQBVABWOPYFQZ-UHFFFAOYSA-N oxygen(2-);titanium(4+) Chemical class [O-2].[O-2].[Ti+4] SOQBVABWOPYFQZ-UHFFFAOYSA-N 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000019809 paraffin wax Nutrition 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229940031709 peg-30-dipolyhydroxystearate Drugs 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229940116257 pepper extract Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 229960000969 phenyl salicylate Drugs 0.000 description 1
- LYXOWKPVTCPORE-UHFFFAOYSA-N phenyl-(4-phenylphenyl)methanone Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1C(=O)C1=CC=CC=C1 LYXOWKPVTCPORE-UHFFFAOYSA-N 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 239000010471 pistachio oil Substances 0.000 description 1
- 229940082415 pistachio oil Drugs 0.000 description 1
- 239000012165 plant wax Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920013639 polyalphaolefin Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- GFFSHIVMOVAQMY-LMOVPXPDSA-M potassium;(2s)-2-(decanoylamino)-3-(4-hydroxyphenyl)propanoate Chemical compound [K+].CCCCCCCCCC(=O)N[C@H](C([O-])=O)CC1=CC=C(O)C=C1 GFFSHIVMOVAQMY-LMOVPXPDSA-M 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- ZPWFUIUNWDIYCJ-UHFFFAOYSA-N propan-2-yl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(C)C ZPWFUIUNWDIYCJ-UHFFFAOYSA-N 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- DPBVJRXPSXTHOL-UHFFFAOYSA-N propyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCC DPBVJRXPSXTHOL-UHFFFAOYSA-N 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 239000001944 prunus armeniaca kernel oil Substances 0.000 description 1
- 235000015136 pumpkin Nutrition 0.000 description 1
- 235000003499 redwood Nutrition 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 150000003287 riboflavins Chemical class 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 230000021317 sensory perception Effects 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940083542 sodium Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- FWFUWXVFYKCSQA-UHFFFAOYSA-M sodium;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C FWFUWXVFYKCSQA-UHFFFAOYSA-M 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 235000020712 soy bean extract Nutrition 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229940114926 stearate Drugs 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 150000003458 sulfonic acid derivatives Chemical class 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000010491 tara gum Nutrition 0.000 description 1
- 239000000213 tara gum Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- UZVUJVFQFNHRSY-OUTKXMMCSA-J tetrasodium;(2s)-2-[bis(carboxylatomethyl)amino]pentanedioate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CC[C@@H](C([O-])=O)N(CC([O-])=O)CC([O-])=O UZVUJVFQFNHRSY-OUTKXMMCSA-J 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 150000003611 tocopherol derivatives Chemical class 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 150000003918 triazines Chemical class 0.000 description 1
- 235000001019 trigonella foenum-graecum Nutrition 0.000 description 1
- PJHKBYALYHRYSK-UHFFFAOYSA-N triheptanoin Chemical compound CCCCCCC(=O)OCC(OC(=O)CCCCCC)COC(=O)CCCCCC PJHKBYALYHRYSK-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 235000014692 zinc oxide Nutrition 0.000 description 1
- RNWHGQJWIACOKP-UHFFFAOYSA-N zinc;oxygen(2-) Chemical class [O-2].[Zn+2] RNWHGQJWIACOKP-UHFFFAOYSA-N 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
- WHNFPRLDDSXQCL-UAZQEYIDSA-N α-msh Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(N)=O)NC(=O)[C@H](CO)NC(C)=O)C1=CC=C(O)C=C1 WHNFPRLDDSXQCL-UAZQEYIDSA-N 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/062—Oil-in-water emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/29—Titanium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
- A61K8/415—Aminophenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4966—Triazines or their condensed derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
Definitions
- the subject of the invention is a novel method for improving the sensory and esthetic properties of an oil-in-water type emulsion on human skin.
- the objective of a large number of cosmetic formulations for topical application is to protect the skin, the mucous membranes and the scalp against external and environmental attacks and stresses.
- cosmetic formulations for topical application are looking for formulations to be applied to the skin that will protect them against the harmful and unesthetic effects of prolonged exposure to ultraviolet radiation from the sun, or that will protect against harmful modifications to the integrity of their skin following increasingly frequent exposure to the polluting agents present in atmospheres, and more particularly urban atmospheres.
- cosmetic and dermocosmetic compositions which give them both feelings of well-being during and after application to the skin, and also an identification with an external appearance of the cosmetic or dermocosmetic formulation, which refers back to a criterion of quality.
- consumers are in search of cosmetic or dermocosmetic compositions, the high consistency of which, known as “richness”, is often associated with a feeling of skin comfort during and after application to the skin.
- This feeling of comfort is reinforced when the step of spreading the cosmetic or dermocosmetic composition is easy, that is to say when its duration is reduced or more specifically is not prolonged as a consequence of resistance on the skin during said spreading and/or when the consumer must apply a high shear force on the skin, also resulting in a higher speed application on spreading and/or in the exerting of a force of higher intensity during said spreading phase.
- cosmetic or dermocosmetic formulations which do not detrimentally modify the external appearance of the skin, for instance by leaving an oily residue in the form of a slight film and, on the contrary, a cosmetic or dermocosmetic formulation which gives the skin a matt appearance will be preferred and sought.
- the external appearance of the cosmetic or dermocosmetic formulation may constitute a criterion of choice and of proven attraction for its use by the consumer.
- a cosmetic or dermocosmetic formulation having a heterogeneous external appearance, showing a slight layer of yellowish oil at the surface after storage will not be considered to be attractive, whereas, on the contrary, a cosmetic or dermocosmetic formulation that is homogeneous after prolonged storage and that has a shiny appearance will be considered to be attractive since it reflects an external image of quality.
- protection and care formulations may be in the form of an oil-in-water type emulsion in order to be able to provide a more pleasant sensation by bringing the skin into contact with an aqueous phase, but the surfactant or polymeric emulsifiers required to maintain the stability of said oil-in-water emulsion may also contribute to discomfort during the application by conferring a sensation of heaviness on the emulsion during and after its application to the skin.
- One alternative may consist of the development of a water-in-oil type emulsion, which is stabilized by thickening of the oily phase using in particular waxes and linear fatty alcohols, the hydrocarbon-based chain of which comprises from 14 to 22 carbon atoms.
- Silicone elastomers are also used to stabilize such a water-in-oil type emulsion, but said silicone elastomers also involve a deterioration of the sensory properties of the skin thus treated by the application of said emulsion.
- the use of these silicone elastomers as stabilizers of water-in-oil antisun emulsions modifies, in some cases, the solubility of the sunscreens used, which can then precipitate from the bottle during storage.
- the formulator In order to avoid being confronted with the drawbacks mentioned above both for water-in-oil type emulsions and for oil-in-water type emulsions, the formulator must develop an emulsion which has improved spreading properties, therefore making it possible for the consumer to apply the emulsion to the skin without being confronted with friction forces contrary to the movement set up by the applicator and therefore slowing down said application and/or requiring a higher spreading speed.
- EP 2 644 188 A1 teaches oil-in-water type emulsions having improved properties of spreading on the skin, comprising a combination of at least one crosslinked and non-emulsifying silicone resin, at least one polyvinyl alcohol, a thickener of polyacrylamide type, an oil chosen from the elements of the group consisting of triglyceride-type plant oils, waxes, ethoxylated fatty alcohols, fatty acid esters, fatty acids, fatty alcohols, silicone oils and perfluoro oils.
- WO 2011/065771 discloses and teaches the spreading and the softness provided during the application of a water-in-oil-in-water type emulsion, prepared from a water-in-oil type emulsion comprising a silicone-based emulsifier, a di-polyhydroxalkyl type emulsifier, a mineral thickener of hectorite type, and a polar oil.
- silicone derivatives such as the chemical substances and compositions of the polysiloxane family are known to give oil-in-water emulsions improved sensory properties, in particular in terms of ease of spreading and of limitation of lipid residues on the skin after application.
- the environmental characteristics associated with these ingredients have required the search for substitutes which provide similar sensory properties while at the same time having environmental characteristics in accordance with the regulations in force and to come, and in accordance with consumer demands on the subject.
- alkane compositions comprising large amounts of cycloalkanes for preparing oil-in-water cosmetic emulsions; said alkane mixtures having biodegradability properties that are satisfactory and sensory properties that are satisfactory but judged to have room for improvement.
- cosmetic or dermocosmetic formulations which have improved sensory properties, in particular which provide a sensation of richness and which are easy to spread on the skin, and which have improved and/or attractive esthetic characteristics, for instance which are characterized by an improved shiny appearance and which give the skin a mattt and non-shiny appearance.
- the inventors have thus sought to develop a new solution for improving the sensory and esthetic properties of an oil-in-water type emulsion for topical use, not necessarily using silicone derivatives, but using chemical compositions of plant and/or biodegradable origins.
- a subject of the invention is a method for improving the sensory and/or esthetic properties of an oil-in-water type emulsion (E 0 ), said sensory properties being the spreading properties and the consistency and richness properties of said topical emulsion (E 0 ), characterized in that an effective amount of a mixture (M 1 ) of cyclic or acyclic, linear or branched saturated hydrocarbons, among which at least 95% by weight comprise 15 to 19 carbon atoms, is incorporated into said oil-in-water type emulsion (E 0 ).
- said oil-in-water type emulsion (E 0 ) is free of shea butter.
- the term “sensory properties” of an oil-in-water (E 0 ) denotes the sensations felt and noted by a user who applies to the skin the oil-in-water type emulsion (E) resulting from said method above and which correspond to physicochemical and/or rheological characteristics of said emulsion (E).
- the term “esthetic properties” denotes visual characteristics associated with the oil-in-water emulsion for use (E) as such and also associated with the condition of the skin after application of said oil-in-water emulsion for topical use (E).
- the term “effective amount” denotes, in the definition of the method as defined above, an amount such that the oil-in-water type emulsion for topical use (E) resulting from said method above: shows a mean value of at least three measurements of the variation in the coefficient of friction, as a function of the velocity of application of between 1 radian.s ⁇ 1 and 4 radian.s ⁇ 1 , of less than or equal to 10% of the value initially measured for a velocity of application to the skin equal to 1 radian.s ⁇ 1 ; said coefficients of friction being recorded during each of the measurements by means of a DHR2 rheometer (TA Instruments) equipped with a support of Peltier plate type on which is placed a plexiglass surface on which the emulsion to be tested is deposited.
- TA Instruments T Instruments
- oil-in-water type emulsion denotes the emulsions comprising, for 100% of their weight:
- oil present in the fatty phase (G 0 ) of the oil-in-water type emulsion (E 0 ) as defined above denotes chemical substances or mixtures of chemical substances that are water-insoluble and that are in liquid form at a temperature of 25° C.
- the term “wax” present in the fatty phase (G 0 ) of the oil-in-water type emulsion (E 0 ) as defined above denotes the chemical substances or the mixtures of chemical substances that are water-insoluble and that are in solid form at a temperature of 45° C.
- water-in-oil type surfactant present in the fatty phase (G 0 ) of the oil-in-water type topical emulsion (E 0 ) as defined above denotes the chemical substance of the mixture of chemical substances that makes it possible to stabilize the droplets of said fatty phase (G 0 ) in dispersion in the continuous phase (A 0 ).
- oil-in-water type surfactant present in the fatty phase)(G 0 ) of the oil-in-water type emulsion (E 0 ) as defined above mention may be made for example of:
- aqueous phase (A 0 ) of the oil-in-water type emulsion means, according to the Council of the European Economic Community Directive no. 76/768/EEC of Jul. 27, 1976, amended by Directive no. 93/35/EEC of Jun. 14, 1993, any substance or preparation intended to be brought into contact with the various parts of the human body (epidermis, body hair and head hair system, nails, lips and genitals) or with the teeth and mucous membranes of the mouth, for the purpose, exclusively and mainly, of cleansing them, fragrancing them, modifying the appearance thereof and/or correcting body odors thereof and/or protecting them or keeping them in good condition.
- a cosmetically acceptable medium of these compositions which are a subject of the invention may conventionally contain water, one or more cosmetically acceptable organic solvents, or a mixture of water and one or more organic solvents.
- the cosmetically acceptable solvents may more particularly be chosen from polyhydric alcohols, for instance glycerol, diglycerol, glycerol oligomers, ethylene glycol, propylene glycol, hexylene glycol, diethylene glycol, xylitol, erythritol, sorbitol, or water-soluble alcohols.
- the term “effective amount of said mixture (M 1 )” denotes a weight proportion of from 1% to 25% of the oil-in-water emulsion, most particularly from 5% to 20%.
- linear alkanes present in the mixture (M 1 ) used in the method which is a subject of the present invention, and comprising from fifteen to nineteen carbon atoms, denotes more particularly the elements chosen from the group consisting of pentadecane, hexadecane, heptadacane, octadecane and nonadecane.
- branched alkanes present in the mixture (M 1 ) used in the method which is a subject of the present invention, and comprising from fifteen to nineteen carbon atoms, denotes more particularly the elements chosen from the group consisting of 2-methyltetradecane (or isopentadecane), 2-methylpentadecane (or isohexadecane), 2-methylhexadecane (or isoheptadecane), 2-methylheptadecane (or isooctadecane) and 2-methyloctadecane (or isononadecane).
- 2-methyltetradecane or isopentadecane
- 2-methylpentadecane or isohexadecane
- 2-methylhexadecane or isoheptadecane
- 2-methylheptadecane or isooctadecane
- 2-methyloctadecane or isononadecane
- cycloalkanes present in the mixture (M 1 ) used in the method which is a subject of the present invention, and comprising from 15 to 19 carbon atoms, denotes more particularly saturated hydrocarbons comprising at least one saturated cyclic hydrocarbon-based group optionally substituted with one or more linear or branched alkyl radicals.
- a subject of the invention is a method as defined above, characterized in that said mixture (M 1 ) comprises, for 100% of its weight:
- the subject of the invention is a method as defined above, wherein (M 1 ) is a mixture of saturated hydrocarbons sold under the brand name EmogreenTML15, comprising, for 100% of its weight:
- cycloalkanes comprising from fifteen to ninteen carbon atoms.
- a subject of the invention is a method as defined above, characterized in that said mixture (M 1 ) comprises, for 100% of its weight:
- the subject of the invention is a method as defined above, wherein (M 1 ) is a mixture of saturated hydrocarbons sold under the brand name EmosmartTML19, comprising, for 100% of its weight:
- cycloalkanes comprising from 15 to 19 carbon atoms.
- the term “properties of spreading on the skin” denotes the capacity for the oil-in-water emulsion that is the subject of the present invention to be spread on the surface of the skin in a thin layer and so as to cover a wide surface area of the skin while at the same time remaining sufficiently concentrated to accomplish its assigned mission by virtue of its composition, for instance the protection of the skin against the consequences of prolonged exposure to ultraviolet radiation from sun if the oil-in-water emulsion contains organic and/or inorganic sunscreens.
- the properties of spreading on the skin of an oil-in-of water type emulsion namely the ease or difficulty in spreading said emulsion on human skin, can be evaluated by implementing various methods, for instance methods which make it possible to measure the yield point values and/or to measure the shear-thinning index, and/or to measure the coefficient of friction, and/or to measure the variation in the coefficient of friction as a function of the rapidity of said spreading.
- the term “richness” of said emulsion for topical use (E 0 ) denotes the sensation provided by the application to the skin of an emulsion for topical use (E 0 ), as defined above, which is characterized by a non-fluid or non-runny compact consistency if subjected solely to the force of gravity, and a presence of the emulsion during spreading on the skin that is significantly greater in comparison with the spreading of water; the term “presence” is thus understood by those skilled in the art to be a sensory perception devoid of an aqueous nature.
- a subject of the invention is the method as defined above, for which the esthetic property is the shininess of the oil-in-water type emulsion for topical use (E 0 ) resulting from said method above.
- the term “shininess” denotes the capacity of the emulsion to reflect incident rays originating from a source of light of the visible spectrum with a given reflection yield.
- a subject of the invention is the method as defined above, for which the esthetic property is the mattt appearance of the skin noted after the application to the skin of an oil-in-water type emulsion for topical use (E 0 ) resulting from said method above.
- the term “matt aspect of the skin” denotes the capacity of the skin to absorb a given proportion of incident rays originating from a source of light of the visible spectrum, said capacity being linked to the thickness and the nature of the residual film of emulsion remaining on the skin after application thereof.
- a subject of the invention is also an oil-in-water type emulsion (E) comprising, for 100% of its weight:
- said oil-in-water type emulsion (E) is free of shea butter.
- fatty phase (G) denotes a fatty substance or a mixture of fatty substances that is insoluble in water and/or in mixtures of water and polar solvents. Such a “fatty phase” may comprise oils and/or waxes. Among the constituent elements of the fatty phase, mention may be made of:
- water-in-oil type surfactant present in the fatty phase (G) of the oil-in-water type emulsion (E) as defined above denotes a chemical substance or the mixture of chemical substances that makes it possible to stabilize the droplets of the fatty phase (G) in dispersion in the continuous phase (A). Mention may for example be made of:
- a cosmetically acceptable aqueous phase (A) included in the oil-in-water emulsion (E) as defined above may conventionally contain one or more cosmetically acceptable organic solvents, or a mixture of water and one or more cosmetically acceptable organic solvents.
- the cosmetically acceptable solvents may more particularly be chosen from polyhydric alcohols, for instance glycerol, diglycerol, triglycerol, glycerol oligomers, xylitol, erythritol, sorbitol, 2-methyl-1,3-propanediol; alkoxylated polyhydric alcohols; glycols, for instance butylene glycol, hexylene glycol, caprylyl glycol or 1,2-octanediol, pentylene glycol or 1,2-pentanediol, monopropylene glycol, dipropylene glycol, isoprene glycol, butyldiglycol, polyethylene glycols, the molecular weight
- agent for protecting against ultraviolet radiation from the sun denotes in particular, in the definition of the oil-in-water type emulsion (E) which is a subject of the present patent application, pigments, organic sunscreens and inorganic sunscreens.
- pigments used as an agent for protecting against ultraviolet radiation from the sun there are for example titanium dioxide, brown iron oxides, yellow iron oxides, black iron oxides or red iron oxides, or else white or colored nacreous pigments such as titanium mica.
- organic sunscreens used as an agent for protecting against ultraviolet radiation from the sun there are for example:
- inorganic sunscreens used as an agent for protecting against ultraviolet radiation from the sun there are for example: titanium oxides, zinc oxides, cerium oxide, zirconium oxide, yellow, red or black iron oxides, chromium oxides.
- These mineral screens may or may not be micronized, may or may not have undergone surface treatments and may be optionally provided in the form of aqueous or oily predispersions.
- a subject of the invention is an oil-in-water emulsion for topical use (E) as defined above, wherein the agent for protecting against ultraviolet radiation from the sun is chosen from the elements of the group consisting of titanium dioxide, 2,4-dihydroxybenzophenone, 2-(4-diethylamino-2-hydroxybenzoyl)benzoic acid hexyl ester, Ie 2,4-bis ⁇ [4-(2-ethylhexyloxy)-2-hydroxy]phenyl ⁇ -6-(4-methoxyphenyl)-1,3,5-triazine, 2,4,6-tris[4-(2-ethylhexyloxy carbonyl)anilino]-1,3,5-triazine and 2-ethylhexyl dimethoxybenzylidene dioxoimidazolidine propionate.
- the agent for protecting against ultraviolet radiation from the sun is chosen from the elements of the group consisting of titanium dioxide, 2,4-dihydroxybenzophenone,
- a subject of the invention is an oil-in-water emulsion (E) as defined above, characterized in that said mixture (M 1 ) comprises, for 100% of its weight:
- said mixture (M 1 ) is more particularly a mixture of saturated hydrocarbons sold under the brand name EmogreenTML15, comprising, for 100% of its weight:
- cycloalkanes comprising from fifteen to ninteen carbon atoms.
- oil-in-water type emulsion (E) as defined above is characterized in that said mixture (M 1 ) comprises, for 100% of its weight:
- the mixture (M 1 ) is more particularly a mixture of saturated hydrocarbons sold under the brand name EmosmartTML19, comprising, for 100% of its weight:
- cycloalkanes comprising from 15 to 19 carbon atoms.
- the emulsion (E) as defined above may comprise one or more adjuvants such as:
- R′ 3 represents a hydrogen atom or a methyl radical
- R′ 4 represents a linear or branched alkyl radical comprising from eight to thirty carbon atoms and n represents a number greater than or equal to one and less than or equal to 50
- the linear or branched or crosslinked polymers of polyelectrolyte type that can be combined with the oil-in-water emulsion that is a subject of the present invention may be in the form of a solution, of an aqueous suspension, of a water-in-oil emulsion, of an oil-in-water emulsion or of a powder, for example the products sold under the names SimulgelTM EG, SimulgelTMEPG, SepigelTM 305, SimulgelTM 600, SimulgelTM NS, SimulgelTM INS 100, SimulgelTM FL, SimulgelTM A, SimulgelTM SMS 88, SepinovTMEMT 10, SepiplusTM400, SepiplusTM265, SepiplusTMS, Sepi
- y represents a decimal number between 1 and 5
- S represents the residue of a reducing sugar
- R 2 represents a linear or branched, saturated or unsaturated alkyl radical having from 5 to 16 carbon atoms, preferably from 8 to 14 carbon atoms, or a mixture of compounds of formula (II), for example caprylyl capryl glucosides, sold in particular under the brand name OramixTMCG 110, decylglucoside, sold in particular under the brand name OramixTMNS 10;
- a subject of the invention is also the use of an oil-water-type emulsion for topical use (E) as defined above, for protecting human skin against the unesthetic effects of exposure to ultraviolet radiation from the sun, and more particularly against redness.
- E oil-water-type emulsion for topical use
- a subject of the invention is also an oil-in-water type emulsion (E) comprising, for 100% of its weight:
- said oil-in-water type emulsion (E) is free of shea butter.
- Emulsion Fatty phase Sepinov TMEMT10 2% 2% 2% 2% 2% 2% 2% 2% 2% 2% 2% 2% Isohexadecane 15% 0% 0% 0% 0% 0% DC 345 (5) 0% 15% 0% 0% 0% 0% DC 245 (6) 0% 0% 15% 0% 0% Emosmart TML15 (7) 0% 0% 0% 15% 0% Emosmart TMV21 (8) 0% 0% 0% 0% 0% 15% Aqueous phase Water qs 100% qs 100% qs 100% qs 100% qs 100% qs 100% Oramix TMNS10 0.3% 0.3% 0.3% 0.3% 0.3% (5) (DC 345): Emollient used in cosmetics for the sensory properties that it provides and more particularly the ease of spreading that it confers on the emulsion containing it (INCI name: cyclopentasiloxane & cyclohexasiloxane); (6) (DC 245): Emollient used in cosmetic
- the spreading properties of an oil-in-water emulsion are evaluated by the variation in a mean of measurements of the value of the coefficient of friction of said emulsion, carried out using a rheometer of type DHR2 (from the company Texas Instruments), for various spreading speeds.
- the measurements are carried out by means of a DHR2 rheometer (TA Instruments) equipped with the “Tribo Ring on Plate” accessory on which is placed a surface of plexiglass onto which the emulsion to be tested is deposited.
- An amount of the emulsion to be tested is deposited, using a calibrated spreader, such that it forms a thickness of 90 micrometers on the plate.
- the maximum normal force of friction to which the Peltier plate is subjected during the rotation of the geometry is measured.
- the negative variation of the mean of the coefficients of friction, between a velocity of 1 radian.s ⁇ 1 and a velocity of 4 radian.s ⁇ 1 shows an additional technical benefit, namely the obtaining of a lower mean value of the coefficient of friction for a low velocity, that is to say a possibility of spreading the emulsion according to the invention on the skin more easily.
- the procedure carried out comprises 5 steps which are the following:
- This procedure is carried out at a temperature of 20° C.
- each panellist indicates whether said emulsion tested provides an improved sensation compared with the reference emulsion. All of the evaluations are collected and the data are statistically processed so as to determine the significant nature of any difference, improvement or degradation, between the sensation perceived for the emulsion tested and the reference emulsion.
- Emulsion (F 4 ) Reference Emulsion: Emulsion (F 4 )
- the emulsions according to the invention (E 1 ) and (E 3 ), and also the comparative emulsions (F 2 ) and (F 5 ) are evaluated according to the protocol defined above, and the results obtained are recorded in table 4 below.
- the improvement in the sensation of richness compared with (F 4 ) is denoted “>(F 4 )” and the deterioration of the sensation of richness compared with (F 4 ) is denoted “ ⁇ (F 4 )” at each moment of the spreading process.
- Emulsion (F 4 ) Reference Emulsion: Emulsion (F 4 )
- the emulsions according to the invention (E 1 ) and (E 3 ), and also the comparative emulsions (F 2 ) and (F 5 ) are evaluated according to the protocol defined above, and the results obtained are recorded in table 5 below.
- the increase in the shininess of the skin compared with (F 4 ) is denoted “>(F 4 )” and its decrease is denoted “ ⁇ (F 4 )”.
- the emulsions according to the invention (E 1 ) and (E 3 ), and also the comparative emulsions (F 2 ) and (F 5 ) are evaluated according to the protocol defined above, and the results obtained are recorded in table 5 below.
- the increase in the shininess of the emulsion compared with (F 4 ) is denoted “>(F 4 )” and its decrease is denoted “ ⁇ (F 4 )”.
- High UV protection antisun fluid Ingredients % (by weight) Montanov TM 82 2.00% C12-15 Alkyl Benzoate 17.00% Octocrylene 6.00% Ethylhexyl Methoxycinnamate 6.00% Bis-Ethylhexylphenol Methoxyphenyl triazine 3.00% Emogreen TML19 3.00% Tocopherol 0.05% Polyacrylate Crosspolymer-6 (SEPIMAX TM ZEN) 0.25% Cyclopentasiloxane 5.00% Titanium Dioxide And Isohexadecane And 5.40% Triethylhexanoin And Aluminum Stearate And Alumina And Polyhydroxystearic Acid Water qs 100% Methylene Bis-Benzotriazolyl Tetramethylbutylphenol 10.00% Citric Acid qs pH 5.5 Aquaxyl TM 3.00% Phenoxyethanol Ethylhexylglycerin 1.00% Fragrance 0.20%
- High UV protection antisun fluid Ingredients % (by weight) Montanov TM 82 2.00% C12-15 Alkyl Benzoate 17.00% Octocrylene 6.00% Ethylhexyl Methoxycinnamate 6.00% 2-Ethylhexyl dimethoxybenzylidene 3.00% dioxoimidazolidine propionate Emogreen TML15 3.00% Tocopherol 0.05% Polyacrylate Crosspolymer-6 (SEPIMAX TM ZEN) 0.25% Cyclopentasiloxane 5.00% Titanium Dioxide And Isohexadecane And 5.40% Triethylhexanoin And Aluminum Stearate And Alumina And Polyhydroxystearic Acid Water qs 100% Methylene Bis-Benzotriazolyl Tetramethylbutylphenol 10.00% Citric Acid qs pH 5.5 Aquaxyl TM 3.00% Phenoxyethanol Ethylhexylglycerin 1.00% Frag
- SEPIMAXTM Zen Polyacrylate Crosspolymer-6 is a thickening and stabilizing anionic polymer sold by the company SEPPIC.
- EasynovTM (Octyldodecanol & Octydodecyl Xyloside & PEG-30 Dipolyhydroxystearate) is a water-in-oil type emulsifier sold by the company SEPPIC.
- SolagumTM AX (Acacia Senegal Gum and Xanthan Gum) is a thickening and stabilizing polymer of natural origin, sold by the company SEPPIC.
- MontanovTM 82 (Cetearyl Alcohol & Cocoglucoside) is an oil-in-water type emulsifier sold by the company SEPPIC.
- AquaxylTM (Xylitylglucoside and Anhydroxylitol and Xylitol) is a moisturizing active agent sold by the company SEPPIC.
- SepicideTM HB (Phenoxyethanol & Methylparaben & Ethylparaben & Propylparaben & Butylparaben) is a preserving composition sold by the company SEPPIC.
- Citrus Waterfall fragrance concentrate is sold by the company Mane.
- MontanovTM 202 (Arachidyl Alcohol (and) Behenyl Alcohol (and) Arachidyl Glucoside) is an oil-in-water type emulsifier sold by the company SEPPIC.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cosmetics (AREA)
- Colloid Chemistry (AREA)
Abstract
Description
- The subject of the invention is a novel method for improving the sensory and esthetic properties of an oil-in-water type emulsion on human skin.
- The objective of a large number of cosmetic formulations for topical application is to protect the skin, the mucous membranes and the scalp against external and environmental attacks and stresses. For example, consumers are looking for formulations to be applied to the skin that will protect them against the harmful and unesthetic effects of prolonged exposure to ultraviolet radiation from the sun, or that will protect against harmful modifications to the integrity of their skin following increasingly frequent exposure to the polluting agents present in atmospheres, and more particularly urban atmospheres.
- To meet these demands aimed at maintaining and/or restoring skin integrity in the face of identified external elements or natural aging, the cosmetics and dermocosmetics industries have over the past few decades developed new specific ingredients for improving the performance levels required by consumers.
- Furthermore, consumers are also waiting for properties of sensory and esthetic types provided by cosmetic and dermocosmetic compositions, which give them both feelings of well-being during and after application to the skin, and also an identification with an external appearance of the cosmetic or dermocosmetic formulation, which refers back to a criterion of quality. Thus, consumers are in search of cosmetic or dermocosmetic compositions, the high consistency of which, known as “richness”, is often associated with a feeling of skin comfort during and after application to the skin. This feeling of comfort is reinforced when the step of spreading the cosmetic or dermocosmetic composition is easy, that is to say when its duration is reduced or more specifically is not prolonged as a consequence of resistance on the skin during said spreading and/or when the consumer must apply a high shear force on the skin, also resulting in a higher speed application on spreading and/or in the exerting of a force of higher intensity during said spreading phase.
- In specific cases, for instance those of cosmetic or dermocosmetic formulations intended for prevention against the adverse effects (redness, erythema and burns) of ultraviolet radiation from the sun on the skin or those of creams intended for anti-inflammatory and antirheumatic treatments by local application, comprising for example ibuprofen, camphor, diclofenac or clove oil, which are characterized by difficulties in using them during spreading, it has been observed that consumers are less rigorous in the implementation of the procedures for application of said protection or care products. They thus often apply too little product and/or at a frequency that is not sufficiently maintained, and this then results in less protection of the skin than that provided for in the information sheet and/or on the packaging.
- Thus, in order to encourage better and more frequent application of these prevention and protection formulations for the skin, it is important for said formulations to have pleasant sensory properties and for it to be possible to spread them on the skin uniformly and rapidly, without involving too great an application intensity.
- Furthermore, consumers seek cosmetic or dermocosmetic formulations which do not detrimentally modify the external appearance of the skin, for instance by leaving an oily residue in the form of a slight film and, on the contrary, a cosmetic or dermocosmetic formulation which gives the skin a matt appearance will be preferred and sought.
- Finally, the external appearance of the cosmetic or dermocosmetic formulation may constitute a criterion of choice and of proven attraction for its use by the consumer. Thus, a cosmetic or dermocosmetic formulation having a heterogeneous external appearance, showing a slight layer of yellowish oil at the surface after storage will not be considered to be attractive, whereas, on the contrary, a cosmetic or dermocosmetic formulation that is homogeneous after prolonged storage and that has a shiny appearance will be considered to be attractive since it reflects an external image of quality.
- Taking all these requirements into consideration, those skilled in the art can only note that a large number of protection and care products, for instance antisun products or products for topical treatment of inflammations, which show great efficacy, nevertheless cause greasy and unpleasant sensations when they are spread on the skin, said spreading having to be carried out in a relatively long period of time requiring a greater application speed.
- These protection and care formulations may be in the form of an oil-in-water type emulsion in order to be able to provide a more pleasant sensation by bringing the skin into contact with an aqueous phase, but the surfactant or polymeric emulsifiers required to maintain the stability of said oil-in-water emulsion may also contribute to discomfort during the application by conferring a sensation of heaviness on the emulsion during and after its application to the skin.
- One alternative may consist of the development of a water-in-oil type emulsion, which is stabilized by thickening of the oily phase using in particular waxes and linear fatty alcohols, the hydrocarbon-based chain of which comprises from 14 to 22 carbon atoms. Silicone elastomers are also used to stabilize such a water-in-oil type emulsion, but said silicone elastomers also involve a deterioration of the sensory properties of the skin thus treated by the application of said emulsion. Moreover, the use of these silicone elastomers as stabilizers of water-in-oil antisun emulsions modifies, in some cases, the solubility of the sunscreens used, which can then precipitate from the bottle during storage.
- In order to avoid being confronted with the drawbacks mentioned above both for water-in-oil type emulsions and for oil-in-water type emulsions, the formulator must develop an emulsion which has improved spreading properties, therefore making it possible for the consumer to apply the emulsion to the skin without being confronted with friction forces contrary to the movement set up by the applicator and therefore slowing down said application and/or requiring a higher spreading speed.
- European patent application published under number EP 2 644 188 A1 teaches oil-in-water type emulsions having improved properties of spreading on the skin, comprising a combination of at least one crosslinked and non-emulsifying silicone resin, at least one polyvinyl alcohol, a thickener of polyacrylamide type, an oil chosen from the elements of the group consisting of triglyceride-type plant oils, waxes, ethoxylated fatty alcohols, fatty acid esters, fatty acids, fatty alcohols, silicone oils and perfluoro oils.
- The international application published under number WO 2011/065771 discloses and teaches the spreading and the softness provided during the application of a water-in-oil-in-water type emulsion, prepared from a water-in-oil type emulsion comprising a silicone-based emulsifier, a di-polyhydroxalkyl type emulsifier, a mineral thickener of hectorite type, and a polar oil.
- These prior art solutions describe an improvement in the spreading properties of an emulsion by using silicone compounds and other surfactants for which those skilled in the art seek an alternative in an approach where sustainable development is taken into account, and more particularly in an approach where use is made of ingredients that do not emit, and/or the production of which does not involve, volatile organic compounds (VOCs) and/or where use is made of biodegradable ingredients according to the regulatory standards in force and/or where use is made of ingredients of plant and no longer fossil origin. Some of the esthetic properties sought, for instance those aimed at giving the skin a mattt appearance, are achieved by using, in the cosmetic formulation, polymers considered to be plastics and thus which an alternative to obtaining a mattt effect on the skin is sought.
- More specifically, silicone derivatives, such as the chemical substances and compositions of the polysiloxane family are known to give oil-in-water emulsions improved sensory properties, in particular in terms of ease of spreading and of limitation of lipid residues on the skin after application. However, the environmental characteristics associated with these ingredients have required the search for substitutes which provide similar sensory properties while at the same time having environmental characteristics in accordance with the regulations in force and to come, and in accordance with consumer demands on the subject. A partially satisfactory alternative has been demonstrated, by the use of alkane compositions comprising large amounts of cycloalkanes for preparing oil-in-water cosmetic emulsions; said alkane mixtures having biodegradability properties that are satisfactory and sensory properties that are satisfactory but judged to have room for improvement.
- Consequently, there is a need to develop cosmetic or dermocosmetic formulations which have improved sensory properties, in particular which provide a sensation of richness and which are easy to spread on the skin, and which have improved and/or attractive esthetic characteristics, for instance which are characterized by an improved shiny appearance and which give the skin a mattt and non-shiny appearance.
- The inventors have thus sought to develop a new solution for improving the sensory and esthetic properties of an oil-in-water type emulsion for topical use, not necessarily using silicone derivatives, but using chemical compositions of plant and/or biodegradable origins.
- Consequently, according to a first aspect, a subject of the invention is a method for improving the sensory and/or esthetic properties of an oil-in-water type emulsion (E0), said sensory properties being the spreading properties and the consistency and richness properties of said topical emulsion (E0), characterized in that an effective amount of a mixture (M1) of cyclic or acyclic, linear or branched saturated hydrocarbons, among which at least 95% by weight comprise 15 to 19 carbon atoms, is incorporated into said oil-in-water type emulsion (E0).
- According to one particular aspect, said oil-in-water type emulsion (E0) is free of shea butter.
- For the purposes of the present invention, the term “sensory properties” of an oil-in-water (E0) denotes the sensations felt and noted by a user who applies to the skin the oil-in-water type emulsion (E) resulting from said method above and which correspond to physicochemical and/or rheological characteristics of said emulsion (E).
- For the purposes of the present invention, the term “esthetic properties” denotes visual characteristics associated with the oil-in-water emulsion for use (E) as such and also associated with the condition of the skin after application of said oil-in-water emulsion for topical use (E).
- The term “effective amount” denotes, in the definition of the method as defined above, an amount such that the oil-in-water type emulsion for topical use (E) resulting from said method above: shows a mean value of at least three measurements of the variation in the coefficient of friction, as a function of the velocity of application of between 1 radian.s−1 and 4 radian.s−1, of less than or equal to 10% of the value initially measured for a velocity of application to the skin equal to 1 radian.s−1; said coefficients of friction being recorded during each of the measurements by means of a DHR2 rheometer (TA Instruments) equipped with a support of Peltier plate type on which is placed a plexiglass surface on which the emulsion to be tested is deposited.
- For the purposes of the present invention, the term “oil-in-water type emulsion (E0)” denotes the emulsions comprising, for 100% of their weight:
-
- from 95% to 50%, more particularly from 90% to 70% of a cosmetically acceptable aqueous phase (A0);
- from 5% to 50%, more particularly from 10% to 30% of a fatty phase (G0), said fatty phase (G0) comprising, for 100% of its weight, from 1% to 12%, more particularly from 2% to 8% of at least one oil-in-water type surfactant and from 88% to 99%, more particularly from 92% to 98% of at least one oil and/or one wax.
- For the purposes of the invention, the term “oil” present in the fatty phase (G0) of the oil-in-water type emulsion (E0) as defined above denotes chemical substances or mixtures of chemical substances that are water-insoluble and that are in liquid form at a temperature of 25° C.
- For the purposes of the invention, the term “wax” present in the fatty phase (G0) of the oil-in-water type emulsion (E0) as defined above denotes the chemical substances or the mixtures of chemical substances that are water-insoluble and that are in solid form at a temperature of 45° C.
- For the purposes of the present invention, the term “water-in-oil type surfactant” present in the fatty phase (G0) of the oil-in-water type topical emulsion (E0) as defined above denotes the chemical substance of the mixture of chemical substances that makes it possible to stabilize the droplets of said fatty phase (G0) in dispersion in the continuous phase (A0).
- As oil-in-water type surfactant present in the fatty phase)(G0) of the oil-in-water type emulsion (E0) as defined above, mention may be made for example of:
-
- polysorbates resulting from the ethoxylation reaction of one molar equivalent of sorbitan esters and between 5 and 20 molar equivalents of ethylene oxide, and more particularly between one molar equivalent of sorbitan laurate, of sorbitan palmitate, or of sorbitan stearate, or of sorbitan isostearate, or of sorbitan oleate, and between 5 and 20 molar equivalents of ethylene oxide;
- the products resulting from the ethoxylation reaction between one molar equivalent of a fatty acid, for instance palmitic acid, myristic acid, lauric acid, stearic acid, isostearic acid, oleic acid, and between 5 and 40 molar equivalents of ethylene oxide;
- the products resulting from the esterification reaction between a fatty acid, for instance palmitic acid, myristic acid, lauric acid, stearic acid, isostearic acid, oleic acid, arachidic acid, behenic acid, and between 4 and 20 molar equivalents, more particularly between 3 and 10 molar equivalents, of glycerol.
- The expression “cosmetically acceptable” used in the definition of the aqueous phase (A0) of the oil-in-water type emulsion means, according to the Council of the European Economic Community Directive no. 76/768/EEC of Jul. 27, 1976, amended by Directive no. 93/35/EEC of Jun. 14, 1993, any substance or preparation intended to be brought into contact with the various parts of the human body (epidermis, body hair and head hair system, nails, lips and genitals) or with the teeth and mucous membranes of the mouth, for the purpose, exclusively and mainly, of cleansing them, fragrancing them, modifying the appearance thereof and/or correcting body odors thereof and/or protecting them or keeping them in good condition. A cosmetically acceptable medium of these compositions which are a subject of the invention may conventionally contain water, one or more cosmetically acceptable organic solvents, or a mixture of water and one or more organic solvents. The cosmetically acceptable solvents may more particularly be chosen from polyhydric alcohols, for instance glycerol, diglycerol, glycerol oligomers, ethylene glycol, propylene glycol, hexylene glycol, diethylene glycol, xylitol, erythritol, sorbitol, or water-soluble alcohols.
- According to one particular mode of the method as defined above, the term “effective amount of said mixture (M1)” denotes a weight proportion of from 1% to 25% of the oil-in-water emulsion, most particularly from 5% to 20%.
- The expression “for topical use” used in the definition of the method as defined above means that said composition is used by application to the skin, the hair, the scalp or the mucous membranes, whether it is a direct application in the case of a cosmetic, dermocosmetic, dermopharmaceutical or pharmaceutical composition or an indirect application, for example in the case of a body hygiene product in the form of a textile or paper wipe, or sanitary products intended to be in contact with the skin or the mucous membranes.
- For the purposes of the present invention, the term “linear alkanes” present in the mixture (M1) used in the method which is a subject of the present invention, and comprising from fifteen to nineteen carbon atoms, denotes more particularly the elements chosen from the group consisting of pentadecane, hexadecane, heptadacane, octadecane and nonadecane.
- For the purposes of the present invention, the term “branched alkanes” present in the mixture (M1) used in the method which is a subject of the present invention, and comprising from fifteen to nineteen carbon atoms, denotes more particularly the elements chosen from the group consisting of 2-methyltetradecane (or isopentadecane), 2-methylpentadecane (or isohexadecane), 2-methylhexadecane (or isoheptadecane), 2-methylheptadecane (or isooctadecane) and 2-methyloctadecane (or isononadecane).
- For the purposes of the present invention, the term “cycloalkanes” present in the mixture (M1) used in the method which is a subject of the present invention, and comprising from 15 to 19 carbon atoms, denotes more particularly saturated hydrocarbons comprising at least one saturated cyclic hydrocarbon-based group optionally substituted with one or more linear or branched alkyl radicals.
- According to one particular aspect, a subject of the invention is a method as defined above, characterized in that said mixture (M1) comprises, for 100% of its weight:
-
- a weight proportion of branched alkanes of greater than or equal to 80% and less than or equal to 100%, and more particularly greater than or equal to 90%;
- a weight proportion of linear alkanes of greater than or equal to 0% and less than or equal to 15%, and more particularly less than or equal to 10%;
- a weight proportion of cycloalkanes of greater than or equal to 0% and less than or equal to 5%, and more particularly less than or equal to 1%, and in that from 95% by weight to 100% by weight of said cyclic or acyclic, linear or branched hydrocarbons comprise from fifteen to nineteen carbon atoms and in that up to 5% by weight of said cyclic, acyclic, linear or branched hydrocarbons comprise less than fifteen carbon atoms or more than nineteen carbon atoms.
- According to a more particular aspect, the subject of the invention is a method as defined above, wherein (M1) is a mixture of saturated hydrocarbons sold under the brand name Emogreen™L15, comprising, for 100% of its weight:
- i) 3.7% of linear alkanes comprising from fifteen to ninteen carbon atoms,
- ii) 96% of isoalkanes comprising from fifteen to ninteen carbon atoms, and
- iii) 0.3% of cycloalkanes comprising from fifteen to ninteen carbon atoms.
- According to another more particular aspect, a subject of the invention is a method as defined above, characterized in that said mixture (M1) comprises, for 100% of its weight:
-
- a weight proportion of branched alkanes of greater than or equal to 40% and less than or equal to 100%, and more particularly greater than or equal to 50% by weight,
- a weight proportion of linear alkanes of greater than or equal to 0% and less than or equal to 20%, and more particularly less than or equal to 15% by weight,
- a weight proportion of cycloalkanes of greater than or equal to 0% and less than or equal to 40%, and more particularly less than or equal to 35% by weight, and in that 100% by weight of said cyclic or acyclic, linear or branched hydrocarbons comprise from fifteen to nineteen carbon atoms.
- According to a most particular aspect, the subject of the invention is a method as defined above, wherein (M1) is a mixture of saturated hydrocarbons sold under the brand name Emosmart™L19, comprising, for 100% of its weight:
- i) 13.20% by weight of linear alkanes comprising from 15 to 19 carbon atoms,
- ii) 55.00% by weight of isoalkanes comprising from 15 to 19 carbon atoms, and
- iii) 31.80% of cycloalkanes comprising from 15 to 19 carbon atoms.
- For the purposes of the present invention, the term “properties of spreading on the skin” denotes the capacity for the oil-in-water emulsion that is the subject of the present invention to be spread on the surface of the skin in a thin layer and so as to cover a wide surface area of the skin while at the same time remaining sufficiently concentrated to accomplish its assigned mission by virtue of its composition, for instance the protection of the skin against the consequences of prolonged exposure to ultraviolet radiation from sun if the oil-in-water emulsion contains organic and/or inorganic sunscreens. The properties of spreading on the skin of an oil-in-of water type emulsion, namely the ease or difficulty in spreading said emulsion on human skin, can be evaluated by implementing various methods, for instance methods which make it possible to measure the yield point values and/or to measure the shear-thinning index, and/or to measure the coefficient of friction, and/or to measure the variation in the coefficient of friction as a function of the rapidity of said spreading.
- For the purposes of the present invention, the term “richness” of said emulsion for topical use (E0) denotes the sensation provided by the application to the skin of an emulsion for topical use (E0), as defined above, which is characterized by a non-fluid or non-runny compact consistency if subjected solely to the force of gravity, and a presence of the emulsion during spreading on the skin that is significantly greater in comparison with the spreading of water; the term “presence” is thus understood by those skilled in the art to be a sensory perception devoid of an aqueous nature.
- According to another particular aspect, a subject of the invention is the method as defined above, for which the esthetic property is the shininess of the oil-in-water type emulsion for topical use (E0) resulting from said method above. For the purpose of the present invention, the term “shininess” denotes the capacity of the emulsion to reflect incident rays originating from a source of light of the visible spectrum with a given reflection yield.
- According to another particular aspect, a subject of the invention is the method as defined above, for which the esthetic property is the mattt appearance of the skin noted after the application to the skin of an oil-in-water type emulsion for topical use (E0) resulting from said method above. For the purposes of the present invention, the term “matt aspect of the skin” denotes the capacity of the skin to absorb a given proportion of incident rays originating from a source of light of the visible spectrum, said capacity being linked to the thickness and the nature of the residual film of emulsion remaining on the skin after application thereof.
- A subject of the invention is also an oil-in-water type emulsion (E) comprising, for 100% of its weight:
-
- from 50% to 90% by weight, more particularly from 60% to 90% by weight and even more particularly from 70% to 90% by weight of a cosmetically acceptable aqueous phase (A);
- from 10% to 50% by weight, more particularly from 10% to 40% by weight and even more particularly from 10% to 30% by weight of a fatty phase (G) comprising, for 100% of its weight:
- from 10% to 50% by weight, more particularly from 15% to 40% by weight of a mixture (M1) of saturated cyclic or acyclic, linear or branched hydrocarbons among which at least 95% by weight comprise from fifteen to nineteen carbon atoms;
- from 0.5% to 15% by weight, more particularly from 1% to 10% by weight of at least one oil-in-water type surfactant;
- from 5% to 30% by weight, more particularly from 15% to 30% by weight of at least one agent for protection against ultraviolet rays from the sun;
- from 0% to 80% by weight, more particularly from 0% to 60% by weight of at least one oil and/or one wax, it being understood that such an oil and/or such a wax do not correspond to the definition of the mixture (M1).
- According to one particular aspect, said oil-in-water type emulsion (E) is free of shea butter.
- For the purposes of the present invention, the term “fatty phase (G)” denotes a fatty substance or a mixture of fatty substances that is insoluble in water and/or in mixtures of water and polar solvents. Such a “fatty phase” may comprise oils and/or waxes. Among the constituent elements of the fatty phase, mention may be made of:
-
- oils of animal origin, such as squalene or squalane;
- plant oils, such as phytosqualane, sweet almond oil, coconut oil, castor oil, jojoba oil, olive oil, rapeseed oil, groundnut oil, sunflower oil, wheat germ oil, corn germ oil, soybean oil, cottonseed oil, alfalfa oil, poppy oil, pumpkin oil, evening primrose oil, millet oil, barley oil, rye oil, safflower oil, candlenut oil, passionflower oil, hazelnut oil, palm oil, apricot kernel oil, beauty leaf oil, sysymbrium oil, avocado oil, calendula oil, sesame oil, meadowsweet oil, macadamia/kiwi oil, borage oil, blackcurrant oil, coffee oil, pistachio oil, peach kernel oil, rapberry seed oil, strawberry seed oil, melon oil, blueberry seed oil, argan oil, oily plum extract, pomegranate oil, papaya oil, coconut milk oil, and oils derived from flowers or from vegetables;
- ethoxylated plant oils;
- synthetic oils for instance fatty acid esters such as butyl myristate, propyl myristate, cetyl myristate, isopropyl palmitate, butyl stearate, hexadecyl stearate, isopropyl stearate, octyl stearate, isocetyl stearate, dodecyl oleate, hexyl laurate, propylene glycol dicaprylate, esters derived from lanolic acid, such as isopropyl lanolate, isocetyl lanolate, fatty acid monoglycerides, diglycerides and triglycerides, such as glyceryl triheptanoate, alkyl benzoates, hydrogenated oils, poly(alpha-olefins), polyolefins such as polyisobutene, hydrogenated polydecene or hydrogenated polyisobutene, sold in France by the company Ets B. Rossow et Cie under the name Parleam—Polysynlane™, cited in: Michel and Irene Ash; Thesaurus of Chemical Products, Chemical Publishing Co, Inc. 1986 Volume I, page 211 (ISBN 0 7131 3603 0);
- silicone oils such as dimethylpolysiloxanes, methylphenylpolysiloxanes, amine-modified silicones, fatty acid-modified silicones, alcohol-modified silicones, silicones modified with alcohols and fatty acids, silicones modified with polyether groups, epoxy-modified silicones, silicones modified with fluoro groups, cyclic silicones and silicones modified with alkyl groups.
- waxes such as beeswax, carnauba wax, candelilla wax, ouricoury wax, Japan wax, cork fiber wax, sugar cane wax, jojoba wax, blackcurrant flower wax, narcissus flower wax, orange tree flower wax, orange wax, rice wax, paraffin waxes, lignite waxes, microcrystalline waxes, lanolin wax; ozokerite; polyethylene wax; silicone waxes; plant waxes; fatty alcohols and fatty acids that are solid at ambient temperature; glycerides that are solid at ambient temperature.
- The term “water-in-oil type surfactant” present in the fatty phase (G) of the oil-in-water type emulsion (E) as defined above denotes a chemical substance or the mixture of chemical substances that makes it possible to stabilize the droplets of the fatty phase (G) in dispersion in the continuous phase (A). Mention may for example be made of:
-
- polysorbates resulting from the ethoxylation reaction of one molar equivalent of sorbitan esters and between 5 and 20 molar equivalents of ethylene oxide, and more particularly between one molar equivalent of sorbitan laurate, of sorbitan palmitate, or of sorbitan stearate, or of sorbitan isostearate, or of sorbitan oleate, and between 5 and 20 molar equivalents of ethylene oxide;
- the products resulting from the ethoxylation reaction between one molar equivalent of a fatty acid, for instance palmitic acid, myristic acid, lauric acid, stearic acid, isostearic acid, oleic acid, and between 5 and 40 molar equivalents of ethylene oxide;
- the products resulting from the esterification reaction between a fatty acid, for instance palmitic acid, myristic acid, lauric acid, stearic acid, isostearic acid, oleic acid, arachidic acid, behenic acid, and between 4 and 20 molar equivalents, more particularly between 3 and 10 molar equivalents, of glycerol.
- A cosmetically acceptable aqueous phase (A) included in the oil-in-water emulsion (E) as defined above may conventionally contain one or more cosmetically acceptable organic solvents, or a mixture of water and one or more cosmetically acceptable organic solvents. The cosmetically acceptable solvents may more particularly be chosen from polyhydric alcohols, for instance glycerol, diglycerol, triglycerol, glycerol oligomers, xylitol, erythritol, sorbitol, 2-methyl-1,3-propanediol; alkoxylated polyhydric alcohols; glycols, for instance butylene glycol, hexylene glycol, caprylyl glycol or 1,2-octanediol, pentylene glycol or 1,2-pentanediol, monopropylene glycol, dipropylene glycol, isoprene glycol, butyldiglycol, polyethylene glycols, the molecular weight of which is between 200 g·mol−1 and 8000 g·mol−1; or water-soluble alcohols, for instance ethanol, isopropanol or butanol.
- The term “agent for protecting against ultraviolet radiation from the sun” denotes in particular, in the definition of the oil-in-water type emulsion (E) which is a subject of the present patent application, pigments, organic sunscreens and inorganic sunscreens.
- As pigments used as an agent for protecting against ultraviolet radiation from the sun, there are for example titanium dioxide, brown iron oxides, yellow iron oxides, black iron oxides or red iron oxides, or else white or colored nacreous pigments such as titanium mica.
- As organic sunscreens used as an agent for protecting against ultraviolet radiation from the sun, there are for example:
-
- those of the family of benzoic acid derivatives, such as para-aminobenzoic acids (PABAs), in particular monoglyceryl esters of PABA, ethyl esters of N,N-propoxy PABA, ethyl esters of N,N-diethoxy PABA, ethyl esters of N,N-dimethyl PABA, methyl esters of N,N-dimethyl PABA, butyl esters of N,N-dimethyl PABA;
- those of the family of anthranilic acid derivatives, such as homomenthyl-N-acetyl anthranilate;
- those of the family of salicylic acid derivatives, such as amyl salicylate, homomenthyl salicylate, ethylhexyl salicylate, phenyl salicylate, benzyl salicylate, p-isopropanolphenyl salicylate;
- those of the family of cinnamaic acid derivatives, such as ethylhexyl cinnamate, ethyl-4-isopropyl cinnamate, methyl-2,5-diisopropyl cinnamate, p-methoxypropyl cinnamate, p-methoxyisopropyl cinnamate, p-methoxyisoamyl cinnamate, p-methoxyoctyl cinnamate (p-methoxy 2-ethylhexyl cinnamate), p-methoxy 2-ethoxyethyl cinnamate, p-methoxycyclohexyl cinnamate, ethyl-α-cyano-β-phenyl cinnamate, 2-ethylhexyl-□α-cyano-β-phenyl cinnamate, glyceryl diparamethoxy mono-2-ethylhexanoyl cinnamate;
- those of the family of benzophenone derivatives, such as 2,4-dihydroxybenzophenone, 2,2′-dihydroxy-4-methoxybenzophenone, 2,2′,4,4′-tetrahydroxybenzophenone, 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4′-methylbenzophenone, 2-hydroxy 4-methoxy benzophenone-5-sulfonate, 4-phenylbenzophenone, 2-ethylhexyl-4′-phenyl benzophenone-2-carboxylate, 2-hydroxy 4-n-octyloxybenzophenone, 4-hydroxy 3-carboxybenzophenone; 3-(4′-methylbenzylidene)-d,I-camphor, 3-(benzylidene)-d,I-camphor, benzalkonium methosulfate camphor; urocanic acid, ethyl urocanate;
- those of the family of sulfonic acid derivatives, such as 2-phenylbenzimidazole-5-sulfonic acid and salts thereof; the family of triazine derivatives, such as hydroxyphenyltriazine, ethylhexyloxyhydroxyphenyl-4-methoxyphenyltriazine, benzoic acid 2,4,6-trianillino-(p-carbo-2′-ethylhexyl-1′-oxy)-1,3,5-triazine, 4,4-((6-(((1,1-dimethylethyl)amino)carbonyl)phenyl)amino)-1,3,5-triazine-2,4-diyldiimino)bis(2-ethylhexyl) ester, 2-phenyl-5-methylbenzoxazole, 2,2′-hydroxy-5-methylphenylbenzotriazole, 2-(2′-hydroxy-5′-t-octylphenyl)benzotriazole, 2-(2′-hydroxy-5′-methyphenyl)benzotriazole; dibenzazine; dianisoylmethane, 4-methoxy-4″-t-butylbenzoylmethane; 5-(3,3-dimethyl-2-norbornylidene)-3-pentan-2-one; 2-(4-diethylamino-2-hydroxybenzoyl)benzoic acid hexyl ester, 2,4-bis{[4-(2-ethylhexyloxy)-2-hydroxy]phenyl}-6-(4-methoxyphenyl)-1,3,5-triazine, 2,4,6-tris[4-(2-ethylhexyloxycarbonyl)anilino]-1,3,5-triazine, 2-ethylhexyl dimethoxybenzylidene dioxoimidazolidine propionate, the family of diphenylacrylate derivatives, such as 2-ethylhexyl-2-cyano-3,3-diphenyl-2-propenoate, ethyl-2-cyano-3,3-diphenyl-2-propenoate;
- those of the family of polysiloxanes, such as benzylidene siloxane malonate.
- As inorganic sunscreens used as an agent for protecting against ultraviolet radiation from the sun, there are for example: titanium oxides, zinc oxides, cerium oxide, zirconium oxide, yellow, red or black iron oxides, chromium oxides. These mineral screens may or may not be micronized, may or may not have undergone surface treatments and may be optionally provided in the form of aqueous or oily predispersions.
- According to one particular aspect, a subject of the invention is an oil-in-water emulsion for topical use (E) as defined above, wherein the agent for protecting against ultraviolet radiation from the sun is chosen from the elements of the group consisting of titanium dioxide, 2,4-dihydroxybenzophenone, 2-(4-diethylamino-2-hydroxybenzoyl)benzoic acid hexyl ester, Ie 2,4-bis{[4-(2-ethylhexyloxy)-2-hydroxy]phenyl}-6-(4-methoxyphenyl)-1,3,5-triazine, 2,4,6-tris[4-(2-ethylhexyloxy carbonyl)anilino]-1,3,5-triazine and 2-ethylhexyl dimethoxybenzylidene dioxoimidazolidine propionate.
- According to one particular aspect, a subject of the invention is an oil-in-water emulsion (E) as defined above, characterized in that said mixture (M1) comprises, for 100% of its weight:
-
- a weight proportion of branched alkanes of greater than or equal to 80% and less than or equal to 100%, and more particularly greater than or equal to 90% by weight,
- a weight proportion of linear alkanes of greater than or equal to 0% and less than or equal to 15%, and more particularly less than or equal to 10% by weight,
- a weight proportion of cycloalkanes of greater than or equal to 0% and less than or equal to 5%, and more particularly less than or equal to 1% by weight, in that from 95% by weight to 100% by weight of said cyclic or acyclic, linear or branched hydrocarbons comprise from fifteen to nineteen carbon atoms and in that up to 5% by weight of said cyclic, acyclic, linear or branched hydrocarbons comprise less than fifteen carbon atoms or more than nineteen carbon atoms.
- According to this particular aspect, said mixture (M1) is more particularly a mixture of saturated hydrocarbons sold under the brand name Emogreen™L15, comprising, for 100% of its weight:
- i) 3.7% of linear alkanes comprising from fifteen to ninteen carbon atoms,
- ii) 96% of isoalkanes comprising from fifteen to ninteen carbon atoms, and
- iii) 0.3% of cycloalkanes comprising from fifteen to ninteen carbon atoms.
- According to another more particular aspect, the oil-in-water type emulsion (E) as defined above is characterized in that said mixture (M1) comprises, for 100% of its weight:
-
- a weight proportion of branched alkanes of greater than or equal to 40% and less than or equal to 100%, and more particularly greater than or equal to 50% by weight,
- a weight proportion of linear alkanes of greater than or equal to 0% and less than or equal to 20%, and more particularly less than or equal to 15% by weight,
- a weight proportion of cycloalkanes of greater than or equal to 0% and less than or equal to 40%, and more particularly less than or equal to 35% by weight, and in that 100% by weight of said cyclic or acyclic, linear or branched hydrocarbons comprise from fifteen to nineteen carbon atoms.
- According to this particular aspect, the mixture (M1) is more particularly a mixture of saturated hydrocarbons sold under the brand name Emosmart™L19, comprising, for 100% of its weight:
- i) 13.20% by weight of linear alkanes comprising from 15 to 19 carbon atoms,
- ii) 55.00% by weight of isoalkanes comprising from 15 to 19 carbon atoms, and
- iii) 31.80% of cycloalkanes comprising from 15 to 19 carbon atoms.
- The emulsion (E) as defined above may comprise one or more adjuvants such as:
-
- thickeners or gelling agents, for example linear or branched or crosslinked polymers of polyelectrolyte type, such as the partially or totally salified acrylic acid homopolymer, the partially or totally salified methacrylic acid homopolymer, the partially or totally salified 2-methyl-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid (AMPS) homopolymer, copolymers of acrylic acid and of AMPS, copolymers of acrylamide and of AMPS, copolymers of vinylpyrrolidone and of AMPS, copolymers of AMPS and of (2-hydroxyethyl) acrylate, copolymers of AMPS and of (2-hydroxyethyl) methacrylate, copolymers of AMPS and of hydroxyethylacrylamide, copolymers of AMPS and of N,N-dimethylacrylamide, copolymers of AMPS and of tris(hydroxymethyl)acrylamidomethane (THAM), copolymers of acrylic or methacrylic acid and of (2-hydroxyethyl) acrylate, copolymers of acrylic or methacrylic acid and of (2-hydroxyethyl) methacrylate, copolymers of acrylic or methacrylic acid and of hydroxyethylacrylamide, copolymers of acrylic or methacrylic acid and of THAM, copolymers of acrylic or methacrylic acid and of N,N-dimethylacrylamide, terpolymers of acrylic or methacrylic acid, of AMPS and of (2-hydroxyethyl) acrylate, terpolymers of acrylic or methacrylic acid, of AMPS and of (2-hydroxyethyl) methacrylate, terpolymers of acrylic or methacrylic acid, of AMPS and of THAM, terpolymers of acrylic or methacrylic acid, of AMPS and of N,N-dimethylacrylamide, terpolymers of acrylic or methacrylic acid, of AMPS and of acrylamide, copolymers of acrylic acid or methacrylic acid and of alkyl acrylates, the carbon chain of which comprises between 4 and 30 carbon atoms and more particularly between 10 and 30 carbon atoms, copolymers of AMPS and of alkyl acrylates, the carbon chain of which comprises between 4 and 30 carbon atoms and more particularly between 10 and 30 carbon atoms, linear, branched or crosslinked terpolymers of at least one monomer having a free, partially salified or totally salified strong acid function, with at least one neutral monomer, and at least one monomer of formula (VIII):
-
CH2═C(R′3)—C(═O)—[CH2—CH2—O]n—R′4 (VIII) - wherein R′3 represents a hydrogen atom or a methyl radical, R′4 represents a linear or branched alkyl radical comprising from eight to thirty carbon atoms and n represents a number greater than or equal to one and less than or equal to 50; the linear or branched or crosslinked polymers of polyelectrolyte type that can be combined with the oil-in-water emulsion that is a subject of the present invention may be in the form of a solution, of an aqueous suspension, of a water-in-oil emulsion, of an oil-in-water emulsion or of a powder, for example the products sold under the names Simulgel™ EG, Simulgel™EPG, Sepigel™ 305, Simulgel™ 600, Simulgel™ NS, Simulgel™ INS 100, Simulgel™ FL, Simulgel™ A, Simulgel™ SMS 88, Sepinov™EMT 10, Sepiplus™400, Sepiplus™265, Sepiplus™S, Sepimax™Zen, Aristoflex™AVC, Aristoflex™AVS, Novemer™EC-1, Novemer™EC 2, Aristoflex™HMB, Cosmedia™SP, Flocare™ET 25, Flocare™ET 75, Flocare™ET 26, Flocare™ET 30, Flocare™ET 58, Flocare™PSD 30, Viscolam™AT 64, Viscolam™AT 100; polysaccharides consisting only of monosaccharides, such as glucans or glucose homopolymers, glucomannoglucans, xyloglycans, galactomannans of which the degree of substitution (DS) of the D-galactose units on the main chain of D-mannose is between 0 and 1,and more particularly between 1 and 0.25, such as galactomannans originating from cassia gum (DS=⅕), from locust bean gum (DS=¼), from tara gum (DS=⅓), from guar gum (DS=½), from fenugreek gum (DS=1); polysaccharides consisting of monosaccharide derivatives, such as sulfated galactans and more particularly carrageenans and agar, uronans and more particularly algins, alginates and pectins, heteropolymers of monosaccharides and of uronic acids and more particularly xanthan gum, gellan gum, exudates of gum arabic and of karaya gum, glucosaminoglycans; cellulose, cellulose derivatives such as methylcellulose, ethylcellulose, hydroxypropylcellulose, silicates, starch, hydrophilic starch derivatives, polyurethanes;
-
- film-forming compounds;
- hydrotropic agents;
- plasticizers;
- opacifiers or nacreous agents, such as sodium or magnesium palmitate, stearate or hydroxystearate, ethylene or polyethylene glycol monostearates or distearate, fatty alcohols, styrene homopolymers and copolymers, such as the styrene acrylate copolymer sold under the name Montopol™ OP1 by the company SEPPIC;
- texturing agents, such as the lauroyl lysine sold under the name Aminohope™LL by the company Ajinomoto, the octenyl starch succinate sold under the name Dryflo™ by the company National Starch, the myristyl polyglucoside sold by SEPPIC under the name Montanov™ 14, cellulose fibers, cotton fibers, chitosan fibers, talc, sericite, mica;
- overfatting agents;
- sequestrants;
- chelating agents;
- nonionic surfactants such as ethoxylated derivatives of fatty alcohols comprising from 8 to 12 carbon atoms; ethoxylated derivatives of fatty acids comprising from 8 to 12 carbon atoms; ethoxylated derivatives of fatty esters comprising from 8 to 12 carbon atoms; ethoxylated derivatives of monoglycerides comprising from 8 to 12 carbon atoms; alkyl polyglycosides of formula (II):
- wherein y represents a decimal number between 1 and 5, S represents the residue of a reducing sugar and R2 represents a linear or branched, saturated or unsaturated alkyl radical having from 5 to 16 carbon atoms, preferably from 8 to 14 carbon atoms, or a mixture of compounds of formula (II), for example caprylyl capryl glucosides, sold in particular under the brand name Oramix™CG 110, decylglucoside, sold in particular under the brand name Oramix™NS 10;
-
- antioxidants, such as EDTA and salts thereof, citric acid, tartaric acid, oxalic acid, BHA (butylhydroxyanisole), BHT (butylhydroxytoluene), tocopherol derivatives such as tocopheryl acetate, mixtures of antioxidant compounds such as Dissolvine GL 47S (INCI name:
- fragrances;
- preservatives;
- conditioning agents;
- active ingredients intended to provide a treating action with respect to the skin or the hair, such as vitamins and derivatives thereof, especially esters thereof, such as retinol (vitamin A) and the esters thereof (retinyl palmitate, for example), ascorbic acid (vitamin C) and the esters thereof, sugar derivatives of ascorbic acid (such as ascorbyl glucoside), tocopherol (vitamin E) and the esters thereof (such as tocopheryl acetate), vitamin B3 or B10 (niacinamide and derivatives thereof); compounds showing a soothing action, especially Sepicalm™ S, allantoin and bisabolol; anti-inflammatories; compounds showing a moisturizing action, such as urea, hydroxyureas, glycerolglucoside, diglycerolglucoside, polyglycerylglucosides; polyphenol-rich plant extracts, such as grape extracts, pine extracts, wine extracts, olive extracts; compounds showing a slimming or lipolytic action, such as caffeine or derivatives thereof, Adiposlim™, Adipoless™, fucoxanthine; N-acylated proteins; N-acylated peptides, such as Matrixil™; N-acylated amino acids; partial hydrolysates of N-acylated proteins; amino acids; peptides; total protein hydrolysates; soybean extracts, for example Raffermine™; wheat extracts, for example Tensine™ or Gliadine™; plant extracts, such as tannin-rich plant extracts, isoflavone-rich plant extracts or terpene-rich plant extracts; extracts of freshwater or seawater algae; marine plant extracts; marine extracts in general, such as corals; essential waxes; bacterial extracts; ceramides; phospholipids; compounds showing an antimicrobial action or a purifying action, such as Lipacide™ C8G, Lipacide™ UG, Sepicontrol™ A5; Octopirox™ or Sensiva™ SC50; compounds showing an energizing or stimulating property, such as Physiogenyl™, panthenol and derivatives thereof, such as Sepicap™ MP; anti-aging active agents, such as Sepilift™ DPHP, Lipacide™ PVB, Sepivinol™, Sepivital™, Manoliva™, Phyto-Age™, Timecode™; Survicode™; anti-photoaging active agents; agents for protecting the integrity of the dermoepidermal junction; active agents for increasing the synthesis of extracellular matrix components such as collagen, elastins, glycosaminoglycans; active agents which act favorably on chemical cell communication, such as cytokines, or physical cell communication, such as integrins; active agents which create a “heating” sensation on the skin, such as skin microcirculation activators (such as nicotinic acid derivatives) or products which create a feeling of “freshness” on the skin (such as menthol and derivatives); active agents for improving skin microcirculation, for example veinotonics; draining active agents; active agents for decongestive purposes, such as extracts of ginko biloba, of ivy, of horse chestnut, of bamboo, of ruscus, of butcher's broom, of Centalla asiatica, of fucus, of rosemary, of willow; agents for tanning or browning the skin, for instance dihydroxyacetone (DHA), erythrulose, mesotartaric aldehyde, glutaraldehyde, glyceraldehyde, alloxane, ninhydrin, plant extracts, for instance extracts of redwood of the genus Pterocarpus and of the genus Baphia, such as Pteropcarpus santalinus, Pterocarpus osun, Pterocarpus soyauxii, Pterocarpus erinaceus, Pterocarpus indicus or Baphia nitida, such as those described in European patent application EP 0 971 683; agents known for their action of facilitating and/or accelerating tanning and/or browning of the human skin and/or for their action of coloring the human skin, for example carotenoids (and more particularly beta-carotene and gamma-carotene), the product sold under the trade name “Carrot oil” (INCI name: Daucus Carota, helianthus annuus Sunflower oil) by Provital, which contains carotenoids, vitamin E and vitamin K; tyrosine and/or the derivatives thereof, known for their effect on accelerating tanning of the human skin in combination with exposure to ultraviolet radiation, for instance the product sold under the trade name “SunTan Accelerator™” by Provital, which contains tyrosine and riboflavins (vitamin B), the tyrosine and tyrosinase complex sold under the trade name “Zymo Tan Complex” by Zymo Line, the product sold under the trade name MelanoBronze™ (INCI name: Acetyl Tyrosine, Monk's pepper extract (Vitex Agnus-castus)) by the company Mibelle, which contains acetyl tyrosine, the product sold under the trade name Unipertan VEG-24/242/2002 (INCI name: butylene glycol and Acetyl Tyrosine and hydrolyzed vegetable protein and Adenosine triphosphate) by the company Unipex, the product sold under the trade name “Try-Excell™” (INCI name: Oleoyl Tyrosine and Luffa Cylindrica (Seed Oil and Oleic acid) by the company Sederma, which contains extracts of marrow seed (or loofah oil), the product sold under the trade name Actibronze™ (INCI name: hydrolyzed wheat protein and acetyl tyrosine and copper gluconate) by the company Alban Muller, the product sold under the trade name Tyrostan™ (INCI name: potassium caproyl tyrosine) by the company Synerga, the product sold under the trade name Tyrosinol (INCI name: Sorbitan Isostearate, glyceryl oleate, caproyl Tyrosine) by Synerga, the product sold under the trade name InstaBronze™ (INCI name: Dihydroxyacetone and acetyl tyrosine and copper gluconate) sold by the company Alban Muller, the product sold under the trade name Tyrosilane (INCI name: methylsilanol and acetyl tyrosine) by the company Exymol; peptides known for their melanogenesis-activating effect, for example the product sold under the trade name Bronzing SF Peptide powder (INCI name: Dextran and Octapeptide-5) by Infinitec Activos, the product sold under the trade name Melitane (INCI name: Glycerin and Aqua and Dextran and Acetyl hexapeptide-1) comprising the acetyl hexapeptide-1 known for its alpha-MSH agonist action, the product sold under the trade name Melatimes Solutions™ (INCI name: Butylene glycol, Palmitoyl Tripeptide-40) by the company Lipotec, sugars and sugar derivatives, for example the product sold under the trade name Tanositol™ (INCI name: inositol) by the company Provital, the product sold under the trade name Thalitan™ (or Phycosaccharide™ AG) by the company CODIF international (INCI name: Aqua and hydrolyzed algin (Laminaria Digitata) and magnesium sulfate and manganese sulfate) containing an oligosaccharide of marine origin (guluronic acid and mannuronic acid chelated with magnesium and manganese ions), the product sold under the trade name Melactiva™ (INCI name: Maltodextrin, Mucuna Pruriens Seed extract) by the company Alban Muller, flavonoid-rich compounds, for instance the product sold under the trade name “Biotanning” (INCI name: Hydrolyzed citrus Aurantium dulcis fruit extract) by the company Silab and known to be rich in lemon flavonoids (of hesperidin type);
- mineral fillers or pigments, such as titanium dioxide, brown iron oxides, yellow iron oxides, black iron oxides, or red iron oxides or else white or colored nacreous pigments such as titanium mica;
- particles which provide a visual effect or which are intended for the encapsulating of active agents;
- exfoliating particles;
- optical brighteners;
- insect repellents. The oil-in-water emulsion (E) as defined above can be packaged in a bottle, in a device of pump “bottle” type, in the pressurized form in an aerosol device, in a device equipped with a perforated wall such as a grill, or in a device equipped with a roll-on applicator.
- A subject of the invention is also the use of an oil-water-type emulsion for topical use (E) as defined above, for protecting human skin against the unesthetic effects of exposure to ultraviolet radiation from the sun, and more particularly against redness.
- Finally, a subject of the invention is also an oil-in-water type emulsion (E) comprising, for 100% of its weight:
-
- from 50% to 90% by weight, more particularly from 60% to 90% by weight and even more particularly from 70% to 90% by weight of a cosmetically acceptable aqueous phase (A);
- from 10% to 50% by weight, more particularly from 10% to 40% by weight and even more particularly from 10% to 30% by weight of a fatty phase (G) comprising, for 100% of its weight:
- from 10% to 50% by weight, more particularly from 15% to 40% by weight of a mixture (M1) of saturated cyclic or acyclic, linear or branched hydrocarbons among which at least 95% by weight comprise from fifteen to nineteen carbon atoms;
- from 0.5% to 15% by weight, more particularly from 1% to 10% by weight of at least one oil-in-water type surfactant;
- from 5% to 30% by weight, more particularly from 15% to 30% by weight of at least one agent for protection against ultraviolet rays from the sun;
- from 0% to 80% by weight, more particularly from 0% to 60% by weight of at least one oil and/or one wax, it being understood that such an oil and/or such a wax do not correspond to the definition of the mixture (M1) it being understood that such an oil and/or such a wax do not correspond to the definition of the mixture (M1), for use thereof in a therapeutic treatment method intended to prevent and/or treat human skin diseases linked to an exposure to ultraviolet radiation from the sun, more particularly burns, sunburn, erythema, skin cancers.
- According to one particular aspect, said oil-in-water type emulsion (E) is free of shea butter.
- The following examples illustrate the invention without, however, limiting it.
- Four oil-in-water emulsions according to the invention, denoted (E1) to (E4), the weight proportions of the constituents of which are indicated in table 1, and five comparative oil-in-water emulsions denoted (F1) to (F5), the weight proportions of the constituents of which are indicated in table 2 below, are prepared. The common preparation process for the oil-in-water emulsions according to the invention and for the comparative oil-in-water emulsions is as follows:
-
- the oily mixture to be tested is poured into a beaker, at a temperature of 20° C., then where appropriate an optional second oil is gradually dispersed with mechanical stirring at 80 rpm;
- the required amount of the Sepinov™EMT 10 thickener is then added thereto with mechanical stirring at 80 rpm and at 20° C.;
- the aqueous phase comprising the water and the Oramix™NS10 are prepared by mixing in a beaker, at a temperature of 20° C.;
- the mixture then obtained is cooled with stirring of deflocculator type at 1500 revolutions per minute for 20 minutes, then emptied out so as to obtain the desired oil-in-water emulsion.
-
TABLE 1 Fatty phase 2% Emosmart ™L19(2 15% 0% 12% 3% Emogreen ™L15(3) 0% 15% 3% 12% Aqueous phase Water qs 100% qs 100% qs 100% qs 100% Oramix ™NS 10(4) 0.3% 0.3% 0.3% 0.3% (1)(Sepinov ™EMT10): Thickener (INCI name: hydroxyethyl acrylate/acryloyldimethyltaurate acrylate copolymer), (2)(Emosmart ™L19): Mixture of saturated cyclic or acyclic, linear or branched hydrocarbons comprising, for 100% of its weight: i) 13.20% by weight of linear alkanes comprising from 15 to 19 carbon atoms, ii) 55.00% by weight of isoalkanes comprising from 15 to 19 carbon atoms, iii) 31.80% of cycloalkanes comprising from 15 to 19 carbon atoms; (3)(Emogreen ™L15): Composition comprising, for 100% of its weight: i) 3.7% of linear alkanes comprising from 15 to 19 carbon atoms, ii) 96% of isoalkanes comprising from 15 to 19 carbon atoms, iii) 0.3% of cycloalkanes comprising from 15 to 19 carbon atoms; (4)(Oramix ™NS10): solubilizing foaming agent (INCI name: capryloyl/capryl glucoside). indicates data missing or illegible when filed -
TABLE 2 Emulsion (F1) (F2) (F3) (F4) (F5) Fatty phase Sepinov ™EMT10 2% 2% 2% 2% 2% Isohexadecane 15% 0% 0% 0% 0% DC 345(5) 0% 15% 0% 0% 0% DC 245(6) 0% 0% 15% 0% 0% Emosmart ™L15(7) 0% 0% 0% 15% 0% Emosmart ™V21(8) 0% 0% 0% 0% 15% Aqueous phase Water qs 100% qs 100% qs 100% qs 100% qs 100% Oramix ™NS10 0.3% 0.3% 0.3% 0.3% 0.3% (5)(DC 345): Emollient used in cosmetics for the sensory properties that it provides and more particularly the ease of spreading that it confers on the emulsion containing it (INCI name: cyclopentasiloxane & cyclohexasiloxane); (6)(DC 245): Emollient used in cosmetics for the sensory properties that it provides and more particularly the ease of spreading that it confers on the emulsion containing it (INCI name: cyclopentasiloxane); (7)(Emosmart ™L15): Mixture comprising, for 100% of its weight: i) 9.26% by weight of linear alkanes comprising from 13 to 15 carbon atoms, ii) 39.06% by weight of isoalkanes comprising from 13 to 15 carbon atoms, iii) 51.68% of cycloalkanes comprising from 13 to 15 carbon atoms; (8)(Emosmart ™V21): Mixture comprising, for 100% of its weight: i) 15.99% by weight of linear alkanes comprising from 18 to 21 carbon atoms, ii) 59.90% by weight of isoalkanes comprising from 18 to 21 carbon atoms, iii) 24.11% of cycloalkanes comprising from 18 to 21 carbon atoms. - The spreading properties of an oil-in-water emulsion are evaluated by the variation in a mean of measurements of the value of the coefficient of friction of said emulsion, carried out using a rheometer of type DHR2 (from the company Texas Instruments), for various spreading speeds.
- It involves characterizing each emulsion tested for a mean value of 3 measured values of the coefficient of friction, in normal force, for a velocity of 1 radian.s−1 and of 4 radian.s−1, then calculating the percentage change for the mean obtained at each of the two speeds.
- The measurements are carried out by means of a DHR2 rheometer (TA Instruments) equipped with the “Tribo Ring on Plate” accessory on which is placed a surface of plexiglass onto which the emulsion to be tested is deposited.
- An amount of the emulsion to be tested is deposited, using a calibrated spreader, such that it forms a thickness of 90 micrometers on the plate.
- After deposition of the sample, its calibrated thickness is brought into contact with the “Tribo Ring on Plate” geometry, and a normal force of 2 N and a fixed velocity gradient that can be adjusted to a value of between 0.01 and 15 radian.s−1 are applied.
- The maximum normal force of friction to which the Peltier plate is subjected during the rotation of the geometry is measured.
- For each emulsion tested, and for each performed measurement of the value of the maximum normal force of friction, the coefficient of friction (Cf) is calculated as follows:
-
Cf=(value maximum normal force of friction)/(value normal force applied) - For each emulsion tested, the values obtained during 3 statistically significant measurements, for a fixed velocity at 1 radian.s−1 and for a fixed velocity at 4 radian.s−1, are taken into consideration, and for each of the emulsions tested, the mean value of the values of the coefficients of friction thus experimentally obtained, denoted Cfm1 for a fixed velocity at 1 radian.s−1 and Cfm4 for a fixed velocity at 4 radian.s−1, are calculated.
- The variation (denoted ΔCf) between the mean value of the coefficient of friction obtained for a velocity of 1 radian.s−1 and the mean value of the coefficient of friction obtained for a fixed velocity at 4 radian.s−1 is then calculated as follows:
-
ΔCf=(Cf m1 −Cf m4)/(Cf m1)×100 - The results obtained are recorded in table 3 hereinafter.
-
TABLE 3 Emulsion (E1) (F1) (F2) (F3) Δcf −6.8% +18.2% +17.5% +14.5% - The results recorded in table 3 clearly reveal that the variation in the means of the coefficients of friction, between spreading at a velocity of 1 radian.s−1 and a velocity of 4 radian.s−1, for the emulsion (E1) according to the invention is less than a value of 10% (-6.8%), whereas the comparative emulsions (F2) and (F3), comprising silicone oils known to confer improved spreading on the emulsions that contain them, show a variation in the coefficient of friction of greater than 15% between spreading at a velocity of 1 radian.s−1 and a velocity of 4 radian.s−1.
- These results thus show an improvement in the ease of spreading of the emulsions according to the invention compared with emulsions comprising emollients known to impart an ease of spreading on the emulsions containing them.
- The variation in the means of the coefficients of friction, between spreading at a velocity of 1 radian.s−1 and a velocity of 4 radian.s−1 for the comparative emulsion (F1), comprising isohexadecane, that is to say an isoparaffin comprising 16 carbon atoms, shows a value of 18.2%, that is to say less performance and less ease of spreading for the emulsions comprising this isoparaffin comprising 16 carbon atoms, than for the emulsions according to the invention.
- Finally, the negative variation of the mean of the coefficients of friction, between a velocity of 1 radian.s−1 and a velocity of 4 radian.s−1, shows an additional technical benefit, namely the obtaining of a lower mean value of the coefficient of friction for a low velocity, that is to say a possibility of spreading the emulsion according to the invention on the skin more easily.
- 13 duly trained and authorized panellists evaluated the criteria of “sensation of richness”, of “shininess of the skin” and of “shininess of the emulsion” of oil-in-water emulsions according to the invention and of comparative oil-in-water emulsions, by taking as reference base an emulsion known by those skilled in the art to constitute an emulsion for which the richness criterion is recognized by all of the panellists, and also a comparison reference to be surpassed in order to realize the stated technical problem.
- The procedure carried out comprises 5 steps which are the following:
-
- Step 1: control and evaluation of the appearance and the odor of the oil-in-water emulsion tested,
- Step 2: take-up in the hand: evaluation of the ease of taking hold, and observation of a possible runny appearance,
- Step 3: spreading of the tested emulsion on the skin by circular application to the surface of the skin, at one and the same speed for 10 circular movements, and collection of the sensations perceived at the end of the 10th circular movement,
- Step 4: continuation of the spreading of the tested emulsion on the skin, still by application of the same circular movement until the absence of emulsion film is observed, and gathering of the perceived sensations,
- Step 5: gathering of the perceived sensations after 1 minute after the end of the spreading.
- This procedure is carried out at a temperature of 20° C.
- For each emulsion tested, and for each sensory criterion evaluated, each panellist indicates whether said emulsion tested provides an improved sensation compared with the reference emulsion. All of the evaluations are collected and the data are statistically processed so as to determine the significant nature of any difference, improvement or degradation, between the sensation perceived for the emulsion tested and the reference emulsion.
- The emulsions according to the invention (E1) and (E3), and also the comparative emulsions (F2) and (F5) are evaluated according to the protocol defined above, and the results obtained are recorded in table 4 below. The improvement in the sensation of richness compared with (F4) is denoted “>(F4)” and the deterioration of the sensation of richness compared with (F4) is denoted “<(F4)” at each moment of the spreading process.
-
TABLE 4 Emulsion (E1) (E3) (F2) (F5) Step 1: Visual evaluation >(F4) >(F4) <(F4) <(F4) Step 2: Evaluation of taking hold >(F4) >(F4) <(F4) <(F4) Step 3: Evaluation after the first >(F4) >(F4) <(F4) <(F4) 10 circular movements Step 4: Evaluation after penetration >(F4) >(F4) <(F4) <(F4) Step 5: Evaluation 1 minute after end of >(F4) >(F4) <(F4) <(F4) spreading - The emulsions according to the invention (E1) and (E3), and also the comparative emulsions (F2) and (F5) are evaluated according to the protocol defined above, and the results obtained are recorded in table 5 below. The increase in the shininess of the skin compared with (F4) is denoted “>(F4)” and its decrease is denoted “<(F4)”.
-
TABLE 5 Emulsion (E1) (E3) (F2) (F5) Step 5: Evaluation 1 minute after <(F4) <(F4) >(F4) >(F4) end of spreading - The emulsions according to the invention (E1) and (E3), and also the comparative emulsions (F2) and (F5) are evaluated according to the protocol defined above, and the results obtained are recorded in table 5 below. The increase in the shininess of the emulsion compared with (F4) is denoted “>(F4)” and its decrease is denoted “<(F4)”.
-
TABLE 6 Emulsion (E1) (E3) (F2) (F5) Step 1: Visual evaluation >(F4) >(F4) <(F4) <(F4) -
-
Antisun emulsion Ingredients % (by weight) Polyacrylate Crosspolymer-6 (SEPIMAX ™ ZEN) 0.90% Glycerol 1.50% Water qs 100% Easynov ™ 3.00% EMOGREEN ™L15 12.00% Sepicide ™ HB 1.00% Fragrance 0.30% Titanium Dioxide And Alumina And Stearic Acid 10.00% -
High UV protection antisun fluid Ingredients % (by weight) Montanov ™ 82 2.00% C12-15 Alkyl Benzoate 17.00% Octocrylene 6.00% Ethylhexyl Methoxycinnamate 6.00% Bis-Ethylhexylphenol Methoxyphenyl triazine 3.00% Emogreen ™L19 3.00% Tocopherol 0.05% Polyacrylate Crosspolymer-6 (SEPIMAX ™ ZEN) 0.25% Cyclopentasiloxane 5.00% Titanium Dioxide And Isohexadecane And 5.40% Triethylhexanoin And Aluminum Stearate And Alumina And Polyhydroxystearic Acid Water qs 100% Methylene Bis-Benzotriazolyl Tetramethylbutylphenol 10.00% Citric Acid qs pH 5.5 Aquaxyl ™ 3.00% Phenoxyethanol Ethylhexylglycerin 1.00% Fragrance 0.20% -
High UV protection antisun fluid Ingredients % (by weight) Montanov ™ 82 2.00% C12-15 Alkyl Benzoate 17.00% Octocrylene 6.00% Ethylhexyl Methoxycinnamate 6.00% 2-Ethylhexyl dimethoxybenzylidene 3.00% dioxoimidazolidine propionate Emogreen ™L15 3.00% Tocopherol 0.05% Polyacrylate Crosspolymer-6 (SEPIMAX ™ ZEN) 0.25% Cyclopentasiloxane 5.00% Titanium Dioxide And Isohexadecane And 5.40% Triethylhexanoin And Aluminum Stearate And Alumina And Polyhydroxystearic Acid Water qs 100% Methylene Bis-Benzotriazolyl Tetramethylbutylphenol 10.00% Citric Acid qs pH 5.5 Aquaxyl ™ 3.00% Phenoxyethanol Ethylhexylglycerin 1.00% Fragrance 0.20% -
Hair balm Ingredients % (by weight) Water qs 100% Glycerin 1.50% Propanediol 1.50% Polyacrylate Crosspolymer-6 (SEPIMAX ™ ZEN) 1.50% Cera Alba 2.00% Copernica Cerifera 1.00% Butyrospermum parkii 2.00% Prunus amygdalus dulcis 4.00% Simmondsia chinensis seed oil 6.00% Emogreen ™L15 3.00% Montanov ™ 202 2.50% Cetearyl Alcohol 3.00% Aquaxyl ™ 3.00% Tocopherol & Helianthus annuus seed oil 0.10% Benzyl alcohol & Dehydroacetic acid 0.70% Citrus aurantium peel oil 0.20% Sodium chloride 1.00% Sodium Hydroxide qs pH 5.5 - SEPIMAX™ Zen (Polyacrylate Crosspolymer-6) is a thickening and stabilizing anionic polymer sold by the company SEPPIC.
- Easynov™ (Octyldodecanol & Octydodecyl Xyloside & PEG-30 Dipolyhydroxystearate) is a water-in-oil type emulsifier sold by the company SEPPIC.
- Solagum™ AX (Acacia Senegal Gum and Xanthan Gum) is a thickening and stabilizing polymer of natural origin, sold by the company SEPPIC.
- Montanov™ 82 (Cetearyl Alcohol & Cocoglucoside) is an oil-in-water type emulsifier sold by the company SEPPIC.
- Aquaxyl™ (Xylitylglucoside and Anhydroxylitol and Xylitol) is a moisturizing active agent sold by the company SEPPIC.
- Sepicide™ HB (Phenoxyethanol & Methylparaben & Ethylparaben & Propylparaben & Butylparaben) is a preserving composition sold by the company SEPPIC.
- Citrus Waterfall fragrance concentrate is sold by the company Mane.
- Montanov™ 202 (Arachidyl Alcohol (and) Behenyl Alcohol (and) Arachidyl Glucoside) is an oil-in-water type emulsifier sold by the company SEPPIC.
Claims (20)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1662650 | 2016-12-16 | ||
FR1662650A FR3060322B1 (en) | 2016-12-16 | 2016-12-16 | PROCESS FOR IMPROVING SENSORY PROPERTIES OF OIL-IN-WATER EMULSIONS |
PCT/FR2017/053508 WO2018109354A1 (en) | 2016-12-16 | 2017-12-12 | Method for improving the sensorial properties of oil-in-water emulsions |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2017/053508 A-371-Of-International WO2018109354A1 (en) | 2016-12-16 | 2017-12-12 | Method for improving the sensorial properties of oil-in-water emulsions |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/455,757 Division US20220071861A1 (en) | 2016-12-16 | 2021-11-19 | Method for improving the sensorial properties of oil-in-water emulsions |
Publications (1)
Publication Number | Publication Date |
---|---|
US20200093713A1 true US20200093713A1 (en) | 2020-03-26 |
Family
ID=58609503
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/470,395 Abandoned US20200093713A1 (en) | 2016-12-16 | 2017-12-12 | Method for improving the sensorial properties of oil-in-water emulsions |
US17/455,757 Pending US20220071861A1 (en) | 2016-12-16 | 2021-11-19 | Method for improving the sensorial properties of oil-in-water emulsions |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/455,757 Pending US20220071861A1 (en) | 2016-12-16 | 2021-11-19 | Method for improving the sensorial properties of oil-in-water emulsions |
Country Status (9)
Country | Link |
---|---|
US (2) | US20200093713A1 (en) |
EP (1) | EP3554462A1 (en) |
JP (1) | JP7090082B2 (en) |
KR (3) | KR102712396B1 (en) |
CN (1) | CN110461299B (en) |
AU (2) | AU2017374588C1 (en) |
BR (1) | BR112019012282B1 (en) |
FR (1) | FR3060322B1 (en) |
WO (1) | WO2018109354A1 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3897856A1 (en) * | 2018-12-19 | 2021-10-27 | L V M H Recherche | Oil-in-water emulsified cosmetic with ultraviolet ray-protecting effect |
FR3094212B1 (en) * | 2019-03-28 | 2021-04-09 | Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic | Alkane and ester-based compositions stable on temperature storage, their use as emollients and emulsions comprising them |
EP3795134B1 (en) * | 2019-09-19 | 2023-05-10 | Société d'Exploitation de Produits pour les Industries Chimiques SEPPIC | Perfuming compositions, stable and having good spraying properties |
KR20230115325A (en) | 2020-12-09 | 2023-08-02 | 디에스엠 아이피 어셋츠 비.브이. | Reduction of stickiness of cosmetic composition containing bisoctrizol |
KR20230115321A (en) | 2020-12-09 | 2023-08-02 | 디에스엠 아이피 어셋츠 비.브이. | Increased Solubilization of Iscotrizinol |
US20240041736A1 (en) | 2020-12-09 | 2024-02-08 | Dsm Ip Assets B.V. | Increased solubilization of ethylhexyl triazone |
US20240041723A1 (en) | 2020-12-09 | 2024-02-08 | Dsm Ip Assets B.V. | Reduction of stickiness of cosmetic compositions comprising octocrylene |
JP2023553827A (en) | 2020-12-09 | 2023-12-26 | ディーエスエム アイピー アセッツ ビー.ブイ. | Reducing rancidity of vegetable oils |
US20240009103A1 (en) | 2020-12-09 | 2024-01-11 | Dsm Ip Assets B.V. | Increased solubilization of bemotrizinol |
EP4259076A1 (en) | 2020-12-09 | 2023-10-18 | DSM IP Assets B.V. | Increased solubilization of diethylamino hydroxybenzoyl hexyl benzoate |
EP4444256A1 (en) | 2021-12-08 | 2024-10-16 | DSM IP Assets B.V. | Improve the water resistance of cosmetic compositions comprising ensulizole |
WO2023194289A1 (en) | 2022-04-04 | 2023-10-12 | Dsm Ip Assets B.V. | Improve the water resistance of cosmetic compositions comprising pigments |
WO2023194290A1 (en) | 2022-04-04 | 2023-10-12 | Dsm Ip Assets B.V. | Improvement of the water resistance of cosmetic compositions comprising uv filters |
WO2024042025A1 (en) | 2022-08-22 | 2024-02-29 | Dsm Ip Assets B.V. | Hair dyes leading to an increase of the colour resistance of dyed hair |
WO2024042024A1 (en) | 2022-08-22 | 2024-02-29 | Dsm Ip Assets B.V. | Hair care compositions leading to an increase of the colour resistance of dyed hair |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2761595B1 (en) | 1997-04-04 | 1999-09-17 | Oreal | COMPOSITIONS COMPRISING SANTALINES, SANTARUBINS FOR ARTIFICIAL COLORING OF THE SKIN AND USES THEREOF |
US6013270A (en) * | 1998-04-20 | 2000-01-11 | The Procter & Gamble Company | Skin care kit |
WO2004084844A2 (en) | 2003-03-27 | 2004-10-07 | Dow Corning Corporation | Controlled release compositions |
ES2307014T5 (en) * | 2003-05-16 | 2012-02-17 | Johnson & Johnson Gmbh | CLEAR EMULSIONS OF WATER OIL. |
KR101369649B1 (en) * | 2005-03-04 | 2014-03-06 | 코그니스 아이피 매니지먼트 게엠베하 | Emollients and cosmetic compositions based on special branched hydrocarbons |
WO2006120003A1 (en) * | 2005-05-12 | 2006-11-16 | Basf Aktiengesellschaft | Isoalkane mixture, its preparation and use |
US20070207113A1 (en) * | 2006-02-10 | 2007-09-06 | Melissa Joerger | Personal care and cosmetic compositions comprising renewably-based, biodegradable 1,3-propanediol |
US20070189989A1 (en) * | 2006-02-16 | 2007-08-16 | Cantwell Maggie Y | Cosmetic compositions and methods of making and using the compositions |
US8679556B2 (en) * | 2006-09-22 | 2014-03-25 | Societe Industrielle Limousine D'application Biologique (Silab) | Process for obtaining an active ingredient with an immediate tensor effect on the skin, active ingredient and compositions |
KR101553415B1 (en) * | 2007-06-19 | 2015-09-15 | 코그니스 아이피 매니지먼트 게엠베하 | Hydrocarbon mixtures and use thereof |
KR101655346B1 (en) | 2009-11-27 | 2016-09-08 | (주)아모레퍼시픽 | Cosmetic composition stabilized higher oily part |
JP6071123B2 (en) | 2012-02-10 | 2017-02-01 | 株式会社 資生堂 | Oil-in-water emulsified skin cosmetic |
EP3143981A1 (en) | 2015-09-16 | 2017-03-22 | Total Marketing Services | Biosourced emollient composition |
-
2016
- 2016-12-16 FR FR1662650A patent/FR3060322B1/en active Active
-
2017
- 2017-12-12 AU AU2017374588A patent/AU2017374588C1/en active Active
- 2017-12-12 US US16/470,395 patent/US20200093713A1/en not_active Abandoned
- 2017-12-12 CN CN201780084471.7A patent/CN110461299B/en active Active
- 2017-12-12 JP JP2019531316A patent/JP7090082B2/en active Active
- 2017-12-12 KR KR1020237040985A patent/KR102712396B1/en active IP Right Grant
- 2017-12-12 WO PCT/FR2017/053508 patent/WO2018109354A1/en unknown
- 2017-12-12 BR BR112019012282-6A patent/BR112019012282B1/en active IP Right Grant
- 2017-12-12 EP EP17822400.2A patent/EP3554462A1/en active Pending
- 2017-12-12 KR KR1020247032211A patent/KR20240147736A/en unknown
- 2017-12-12 KR KR1020197019274A patent/KR102608708B1/en active IP Right Grant
-
2021
- 2021-11-19 US US17/455,757 patent/US20220071861A1/en active Pending
-
2024
- 2024-02-15 AU AU2024200987A patent/AU2024200987A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2017374588C1 (en) | 2024-05-02 |
KR102608708B1 (en) | 2023-12-04 |
FR3060322A1 (en) | 2018-06-22 |
AU2017374588B2 (en) | 2023-12-21 |
AU2024200987A1 (en) | 2024-03-07 |
CN110461299A (en) | 2019-11-15 |
KR20190113770A (en) | 2019-10-08 |
KR20230169410A (en) | 2023-12-15 |
BR112019012282A2 (en) | 2019-11-19 |
JP7090082B2 (en) | 2022-06-23 |
WO2018109354A1 (en) | 2018-06-21 |
BR112019012282B1 (en) | 2023-01-31 |
KR102712396B1 (en) | 2024-10-04 |
KR20240147736A (en) | 2024-10-08 |
FR3060322B1 (en) | 2020-01-03 |
EP3554462A1 (en) | 2019-10-23 |
JP2020505320A (en) | 2020-02-20 |
AU2017374588A1 (en) | 2019-07-11 |
CN110461299B (en) | 2023-09-15 |
US20220071861A1 (en) | 2022-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2017374588C1 (en) | Method for improving the sensorial properties of oil-in-water emulsions | |
KR102574933B1 (en) | Method for improving the sensory properties of such glycerin-based oil-in-water emulsions to reduce the adhesive effect of the oil-in-water emulsions | |
EP3073988A1 (en) | Composition of alkyl polyglucosides and fatty esters of cationic amino acids | |
KR20210145779A (en) | Compositions based on alkanes and esters having temperature storage stability, emollients comprising them and their use as emulsions | |
JP7198776B2 (en) | Method for Synthesizing N-Acyl Compounds Without Using Organic Solvents or Acid Chlorides | |
JP7356981B2 (en) | Novel compositions of lipoamino acids and alkanediols, methods for their preparation and cosmetic or pharmaceutical compositions obtained therefrom | |
JP7361035B2 (en) | Process for the preparation of novel compositions of lipoamino acids and diols and cosmetic or pharmaceutical compositions obtained therefrom |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: TOTALENERGIES ONETECH (PREVIOUSLY TOTALENERGIES ONE TECH), FRANCE Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:TOTALENERGIES MARKETING SERVICES (PREVIOUSLY TOTAL MARKETING SERVICES);REEL/FRAME:067096/0320 Effective date: 20231205 |
|
AS | Assignment |
Owner name: TOTALENERGIES ONETECH, FRANCE Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE THE NAME OF THE ASSIGNEE PREVIOUSLY RECORDED AT REEL: 67096 FRAME: 320. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT;ASSIGNOR:TOTALENERGIES MARKETING SERVICES (PREVIOUSLY TOTAL MARKETING SERVICES);REEL/FRAME:067845/0906 Effective date: 20231205 |